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SOMMARIO 
L’utilizzo delle biomasse per la produzione di bio-energia, bio-materiali e bio-molecole 
rappresenta una valida e sostenibile alternativa ai tradizionali processi chimici basati su 
combustibili fossili. 
L’acido lattobionico (ALB) è un fine chemical largamente utilizzato nell’industria alimentare, 
chimica, cosmetica e farmaceutica. E’ prodotto dall’ossidazione del lattosio, ma diversi 
problemi sono connessi alla sua sintesi chimica (processi costosi sia dal punto di vista 
energetico che dal punto di vista dell’impiego di catalizzatori metallici); l’attenzione dunque 
si è spostata verso l’impiego di processi biotecnologici, che utilizzano ceppi batterici in grado 
di utilizzare materiali di scarto per i loro processi metabolici. Questo approccio permette così 
di valorizzare dei sottoprodotti e reflui dell’industria agraria, producendo molecole di alto 
valore aggiunto. 
Questo lavoro ha come obiettivo lo studio della capacità di ceppi batterici di utilizzare il 
lattosio non raffinato della ‘scotta’ per la produzione di ALB. La ‘scotta’ è il sottoprodotto 
ottenuto dai processi di produzione della ricotta, e attualmente viene utilizzato principalmente 
per l’alimentazione del bestiame sebbene presenti un alto contenuto di lattosio (4-5% p/p) e 
circa l’1% di proteine e peptidi che possono essere ulteriormente valorizzati. 
In seguito a screening preliminari per la determinazione delle migliori condizioni operative, 
differenti strategie di scale up sono state investigate al fine di migliorare le rese, nell’ottica di 
un’ implementazione industriale del processo.  
Fermentazioni in reattori a perfetta miscelazione (STR) da 3 L, in condizioni batch,  hanno 
permesso di raggiungere rese di produzione pari a 34,25±2,86 g/L e 30,18±0,3 g/L di ALB 
per due ceppi di Pseudomonas taetrolens (LMG2336 e DSM21104 rispettivamente) con rese 
di conversione intorno all’85%, dopo 48 ore .  
Ulteriori prove in configurazioni fed-batch hanno permesso di raggiungere valori di circa 60 
g/L di ALB, fornendo interessanti prospettive per la messa a punto di un processo in continuo.  
E’ stata anche valutata la possibilità di adoperare matrici ottenute in seguito a procedure di 
ultrafiltrazione e nanofiltrazione della ‘scotta’, finalizzate alla separazione di proteine e 
peptidi bioattivi, ottenendo risultati analoghi, ma promettenti nell’ottica della messa a punto 
di un concetto di bioraffineria integrata per la valorizzazione dei sottoprodotti dell’industria 
lattiero casearia.  
Infine un approccio preliminare di downstrem per il recupero e la purifica dell’ALB prodotto 
dal processo fermentativo, utilizzando membrane ceramiche (idonee ad applicazioni 
xiii 
 
alimentari) in differenti condizioni di pH ha permesso di raggiungere un recupero del 32% a 
pH 9. Anche questo dato è molto promettente nell’ottica di un processo in continuo di 
produzione e purificazione dell’ALB al fine di abbattere i costi. 
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ABSTRACT 
Utilization of biomass as raw material in biorefinery processes is a promising and renewable 
alternative to classic and costly fossil resources for producing bio-energy, bio-materials and 
bio-chemicals. 
Lactobionic acid (LBA) is a fine chemical largely applied in food, chemical, cosmetic and 
pharmaceutical industries. It is obtained from lactose oxidation but several problems with 
chemical synthesis (energy-intensive processes requires the use of costly metal catalysts) have 
been shifted attention in biotechnological processes, employing bacteria strains which are able 
to use cheap raw material in their metabolism pathways. This approach allows to achieve two 
aims: valorisation of agro-industrial wastes producing bio-based fine chemicals. This work 
aimed to investigate bacteria capacity to use a unrefined lactose source as ricotta cheese whey 
(RCW) for LBA production. RCW is the main by-product obtained from ricotta cheese 
production process and is employed mainly for cattle feed, although still contains between 4 
and 5% (w/w) of lactose and up to 1% of protein concentration that can be valorised. 
Following preliminary screening to determine the best operating conditions, different scale-up 
strategies have been investigated in order to improve yields, in view of an industrial 
implementation of the process. 
Fermentations in 3L-StirredTankReactors, in batch conditions, allowed to reach production 
yields of 34.25 ± 2.86 g / L and 30.18 ± 0.3 g / L for LBA for two strains of Pseudomonas 
taetrolens (LMG2336 and DSM21104 respectively) with conversion yields around 85%, after 
48 hours. 
Furthermore fed-batch configurations have allowed to reach values of about 60 g / L of ALB, 
providing interesting perspectives for the development of a continuous process. 
It was also evaluated the possibility to use matrices obtained following procedures of 
ultrafiltration and nanofiltration of the RCW, aimed at the separation of proteins and bioactive 
peptides, obtaining similar results, but promising in view of the setup of a concept point of 
integrated biorefinery for the development of the dairy industry by-products. 
Finally a preliminary approach to the downstream recovery and purifies LBA produced by the 
fermentation process, using ceramic membranes (suitable for food applications) in different 
pH conditions has allowed us to achieve a 32% recovery at pH 9. Even this figure it is very 
promising in view of a continuous process of production and purification Room Christmas 
Tree in order to cut cost 
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1. INTRODUCTION 
Agriculture has always represents the main activity for humans support, but also the deeply 
connection with the Earth. Furthermore its importance is significant from the point of view of 
economic development and environmental impact, and increasingly attention is given to the 
necessity to consider aspects of economic, social and environmental sustainability. 
All food production presents an environmental impact, in terms of energy request and wastes 
production, and the increase of the global demand of food in the last century, concomitant to a 
growing world population, represents an important problem for the institutions and agro-
industrial systems. Minimize environmental impact, producing sufficient high-quality food by 
using available resources, is an important challenge for competitiveness and sustainability. 
(Capper et al., 2009) 
A quantitatively significant of agro-industrial wastes are biodegradable and, therefore, 
susceptible of biochemical transformations which are associable problems and opportunities. 
In general, the ability to recycle and exploit wastes allows reducing disposal costs, 
safeguarding raw materials and limiting environmental impacts. Specifically, the need to 
stabilize the biodegradable wastes is combined with the ability to valorize them from an 
energetic point of view. 
Driven by the gradual depletion of fossil fuels and a growing demand for sustainability, 
chemical companies have seriously begun to consider the 'se of renewable and fermentation 
processes bio-based raw materials for the production of basic chemicals, which in the past 
they were synthesized via purely chemical. Recent developments in microbial genetics and in 
the understanding of cellular metabolic pathways have enabled researchers to develop and 
refine multiple enzymatic steps to convert renewable resources into high value-added 
products through very inexpensive procedures. 
In this context, the global interest is directed towards the marketing of different microbial 
fermentation technology for chemical production. 
Industrial biotechnology is therefore based on the exploitation of the metabolic activity of 
microorganisms, plants and animal cells to produce a wide range of compounds of interest in 
chemical, food, pharmaceutical and healthcare, from industry waste by-products (Parekh, et 
Win al., 2000). According to a market study from FESTEL CAPITAL it is estimated that the 
global share of biotechnological productions, representing approximately 3% in 2004 has 
risen more than 15% in 2015 (Festel Capital 2007). 
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Sustainability of agro-industrial systems represents not only an important solution for 
environmental problems concerned with food production (like emissions and energy security), 
but it play a key role for the economic competitiveness; valorized all the by-products and 
wastes in each production steps led to an increase of the added value of the company, 
avoiding landfill disposal and consumption of additional energy, and maximizing the 
economic value of the starter biomass  (D’Avino et al., 2010).    
Among the several definitions of biorefinery, the most exhaustive was recently formulated by 
the International Energy Agency Bioenergy Task 42 "Biorefinery" (IEA2008): "The 
sustainable processing of biomass into a spectrum of marketable products and energy" 
(Cherubini and Jungmeier, 2010). It is important that the biorefinery system is not only a new 
industrial ideology, but a new concept of integration between agriculture, industry and 
environment (Lazzari, 2012). 
Avoiding, or at least reducing, the dependence from fossil fuels, which maintain market 
dominance, the production process must be reworked through greater integration between the 
different phases, minimizing transport costs and exploitation of the resources locally available 
(bio-fertilizers, additional residues, potential users of products) (Chen et al., 2005) 
Animal products presents important environmental and social consequences, like: animal 
welfare; excessive use of antibiotics; the demand for scarce lands to produce the required 
feed; emission of greenhouse gases; liquids and solids wastes; intensive water consumption 
(Mekonnen and Hoekstra, 2012) and the necessity to reduce all these problems represents a 
significant cost for farmers and industries. 
 
1.1 DAIRY INDUSTRY  
Dairy industry represents all the activities connected with milk production, transformation and 
distribution, and its contributes to worldwide food economy in undoubtedly one of the most 
important.  
The 2007 annual milk yield averaged 9193 kg per cow (compared to 2074 in 1944), which is 
equivalent to 29.3 kg/d when adjusted for a 14-mo calving interval (426 d) and a 60-d dry 
period. In Table 1.1 a comparison between 1944 and 2007 is presented in terms of input, 
output and environmental. The increase in productivity in recent years is demonstrated by the 
percentage of the dairy population required to produce 1 billion kg of milk in 2007; only 21% 
of that required in 1944 (Capper et al., 2009). 
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Despite a decrease after the economic crisis of 2008, dairy production showed a rapid 
recovery, especially connected with high-quality products (Igp and Dop) which absorbed   
about 70% of national milk production. Indeed, in 2011, milk production was about 730 
million tons, up 2.5% from a year earlier (Ismea, 2012).  
Great importance in the international market are countries like India, China, New Zealand, 
Brazil and Argentina, thanks to a strong increase in production since 2009 and upward 
pressure on prices for the intensification of internal demand. Slowed growth for United States, 
Mexico, Canada and Russia (Ismea 2012). 
 
 
Table 1.1. Comparison of resource inputs, waste output, and environmental impact of dairy 
production systems in 1944 and 2007 (Capper et al., 2012). 
 
The European Union is the largest production of milk area with almost 160 million tons 
(considering all species) with annual growth around 1-2% from 2009 onwards. In 2010 the 
old EU countries have provided to market 118.1 million tonnes of milk, while the new 
member countries only 18.1 million tons. This is the result of a 2.3% increase of Community 
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production compared to a year of downturn like 2009. But the gap regards dairy production 
only in terms of weights and volumes of production (over 7.2 million tons account for 1.2 
million tonnes per year). Indeed for the rates of growth and response to the crisis the new EU 
member states are presented more reactive on the market, with a total increase of production 
between 2006 and 2010 that exceed 20%, with the exception of difficult situations for 
Romania and Bulgaria, which they have yet to complete a long process of restructuring and 
adaptation of its dairy industry (Pieri, 2010) 
Italy is one of the best reality at European level for the production of milk occupying fifth 
place behind Germany, France, the United Kingdom and the Netherlands, while for cheese 
production is less in quantity only of Germany and France with a production of over one 
million tons per year. The national value of production achieved from the agricultural sector 
component in 2013 represented the 9.4% of the total of that made by the entire national 
primary sector. Even for the industrial component of the dairy supply chain were recorded 
significant performances. In 2012 dairy industry contributed for 16.5% to the total value of 
the turnover generated by the Italian food industry and for 2% to the entire national 
manufacturing industry. The dairy area was also protagonist of excellent results achieved in 
recent years for agro-food Italian exports. In 2013, in fact, the dairy sector has contributed for 
9.5% to the total value of national agricultural and food exports. In 2012 the national dairy 
industry was consisted of 36000 companies with 68300 workers in terms of ULA (Annual 
Working Unit), 1871 dairy cows, 200000 buffaloes, 6.3 million sheep and 735 thousand 
goats, for a total of 10 million and 900 thousand tons of cow's milk delivered and a monetary 
value of € 3.5 billion. (D’Alessio, 2014). The most productive regions in terms of cow's milk 
are, in fact, in order, Lombardy, Emilia Romagna, Veneto and Piedmont.  Italy mainly exports 
to European Union countries, especially products such as Parmigiano and Grana have seen a 
25% increase in revenues in 2010. On the contrary, competitiveness' price of French and 
Dutch products led to a decrease in exports to the United States. An important data concerns 
the imported milk quantity, in particular from France, Austria and Hungary, with 
quantitatively +9% in 2010  (ISMEA, 2012). 
    
1.1.1 Dairy industry product 
MILK 
Italian legislation defines drinking milk as 'the product obtained through regular, 
uninterrupted and complete from breast of animals in good health and nutrition'. The term 
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"milk" means the only milk cow origin, whereas for raw milk coming from different species 
is compulsory to present a specific indication (RD 994/29). 
In cow's milk components, excluding water, breaks down as follows: 5% lactose, 3.5% fat, 
3.3% protein, less than 1% of mineral salts, trace of enzymes, vitamins , pigments 
(carotenoids, xanthophylls, riboflavine) and dissolved gases (CO2, O2, N2) (Fig. 1.1). Milk is a 
product subject to great variability, due to exogenous (environmental, climate, nutrition) and 
endogenous (breed and individual characteristics) factors, in particular for fats and proteins, 
opposed to lactose molecule that does not present great variation (Ramesh, 1997). 
 
 
 
Fig. 1.1. Milk composition (Ramesh, 1997) 
 
From a physic-chemical point of view milk presents, in addition to a great complex 
composition, a combination of different phases dispersed in aqueous phase which constitutes 
about 87%. Some substances are in solution, while others may be in emulsion, or in colloidal 
dispersion according to their different chemical nature. The components in solution are all 
those soluble in water (salts, lactose, whey protein, water-soluble vitamins), in emulsion we 
find the lipid fraction, while in colloidal suspension are caseins; also in milk are in suspension 
a variable number of cells of a different nature: microbial and somatic (Salvadori Del Prato, 
1998). 
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a)                b)  
Fig. 1.2. Composition milk solids of whole (a) and skim milk (b) (Ramesh, 1997). 
 
Milk contains about 3-3.5% of nitrogenous substances which include milk protein (casein and 
whey proteins, with high biological and nutritional role) and different nitrogenous molecules 
such as, urea, creatine, ammonia, free aminoacids, peptides and nucleic acids (about 5% of all 
nitrogenous substances). Caseins represent about 80% of milk proteins; they become 
insoluble when the milk is acidified (4.6) and exist in milk as spherical particles called 
micelles, which are made up of calcium phosphate and casein complexes stabilizes by surface 
binding. Caseins can be divided into five type with different chemical properties: αs1, αs2, β, 
k-fractions and a γ-fraction, that derived from the breakdown of β-casein by inherent 
proteolytic enzymes of milk. The whey proteins are water soluble protein and have a high 
content of sulphur-amino acids than the casein.  They do not present in large protein 
aggregates but in simple forms such as monomers or polymers. They consist for the most part 
by albumin (70%), and to a lesser extent from globulins (15%), from protease-peptones (10%) 
and from metallic-proteins (5%). Despite casein precipitation occurs by enzymatic action, 
whey protein precipitate with heating or salt addition (Table 1.2) (Ramesh, 1997). 
 
 
Table 1.2. Physical and chemical differences in milk proteins (Ramesh, 1997). 
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Milk lipids represents a fraction between 3 and 4.6%, depending on race and feeding, and 
consist of  97–98% triacylglycerols, 0.2–1% phospholipids, 0.2–0.4% sterols, and traces of 
fatty acids, as well as vitamins A, D, E, and K. Lipids are presented in emulsion in globules 
form; if milk is rich in fat, and the globules are large, phenomena of rancidity are limited. 
Lactose is the only carbohydrate presents in milk (4.5-5%), in two form (α and β) with 
different solubility and sweetness (α-form is less soluble and sweet than β-form). In addition 
to its nutritional role, lactose has a technology importance because is responsible for 
organoleptic changes in milk as a result of heating (Maillard reactions), and being the main 
substrate known to the bacteria in the fermentation of the milk and cheese.  
295/5000 
Lactose is the main energy and carbon source for fermentation during production of yogurt, 
fermented milks and cheeses with reactions as lactic, lacto-alcoholic, propionic but also 
butyric and propionic that led to bulges in late aged cheeses. 
Furthermore milk presents a lot of minor constituents like mineral (<1% include chloride, 
PO4
2+
, and citrates of K
+
, Na
+
, Ca
2+
, and Mg
2+
), important in processing, nutritive value, and 
shelf life of dairy products; vitamins, acting as coenzyme factor, that can be divided in fat-
soluble, water-soluble, thermolabile and thermostable; enzymes, especially oxidoreductases 
and hydrolases, carrying out important actions especially in the process of cheese maturing 
(protease and lipase), in thermal treatments of the milk because they have heat stability 
(alkaline phosphatase) and as indicators of hygienic quality of milk since their amount 
depends on the microbial load.   
Milk at 15°C has a density of 1.028 to 1.033 g/mL with variations according to the title of fat 
and to its composition; to this parameter value contribute both the density of milky plasma 
and of lipid fraction; consequently a skimmed milk has a higher density value compared to 
whole milk. The surface tension of the milk at 15°C is 47-55 Dine /cm² much lower than 
water (72.8 Dine /cm²) which involve good foaming properties, thanks to the proteins that act 
as surfactants, with several implications in technology. Other important physical index is the 
freezing point, the temperature at which the two solid phases coexist and liquid. In this cow's 
milk it is lower than that of pure water and varies from -0.52 to -0.55°C, thanks to the solutes 
present in milk constituted by salts and lactose that being, as already stated, present in 
percentage constant mean that this index does not present big changes, constituting a possible 
indicator of watered down. The pH of the milk at 20°C has values around 6.6 to 6.8 which 
remain constant in the case of addition of small amounts of acids or bases, because milk is a 
buffered solution thanks to the action of proteins which are amphoteric compounds. The pH is 
8 
 
related to the percentage of protein in an inversely proportional way; mastitis milk in fact has 
a higher pH (≥7,0) because the content of total protein decreases while the colostrum milk has 
pH≤6,5 (Salvadori Del Prato, 1998). 
 
CHEESE 
Before the beginning of the processing processes, milk is subjected only to physical 
treatments, such as pasteurisation, which consists in bringing the milk to high temperature 
(70-72°C) for a short time (15-20 seconds) with a subsequent rapid cooling to temperatures of 
less than 6 °C; this treatment limits the presence of pathogenic micro-organisms which are 
sensible to heat. Pasteurization process is necessary especially for fresh cheeses, because for 
long-seasoning cheese the strictly conditions (pH acid, NaCl presence, natural antibiotics) 
limiting the presence of pathogenic microorganisms (Cappelli and Vannucchi, 2005). 
During cheese making process k-casein molecule is cleaved by the enzyme rennin, 
determining destabilization of micelle and consequent curd formation. In the firs parts of the 
cheese making processes, fat does not take part in important activities, but influences  
structure and properties of casein structure, playing an important role in the process of 
maturation  influencing decisively the organoleptic characteristics of the finished product 
(Remesh, 1997). 
The production of cheese (Figure 1.3), called cheese making, consists in a first heating phase 
of the milk following by ferments addition as inoculum, if necessary; it takes place in heated 
boilers, with shape, sizes and materials depending on the type of processing. The second 
phase of the coagulation process is one of the most important steps of the entire process and 
consists in the gelation of casein fraction by precipitation of the micelles (lipoprotein particles 
with tendency to aggregate). Coagulation occurs or by pH reduction,  acidifying the milk 
(acid coagulation), or through the intervention of rennet that modified enzymatically k-
caseina (rennet or enzymatic coagulation). In common cheese making processes, however, it 
employ rennet coagulation, through addition of rennet to milk brought to temperatures of 30-
37°C. The curd is a gelatinous mass of paracaseinato dicalcium that form a three-dimensional 
structure, trapping fat globules and the whey (liquid fraction), and that contract retaining the 
first and expelling the second. Production of lactic acid by the bacteria influence positively 
texture and elasticity of the clot, which contracts and ejects the whey. The lactic acid 
neutralizes the charges on the micelles and, at low levels, making the curd more permeable 
and facilitates the draining of whey attacking partially the paracaseinato dicalcium reticulum. 
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The next stage is the physical breaking of the curd (gelatinous mass of paracaseinato 
dicalcium obtained by the enzymatic action) for expelling the whey and concentrate fat. It is 
achieved through heated to temperatures ranging from 40 to 60°C, for times varying from a 
quarter of an hour up to two hours. After baking, the curd is removed from the coagulation 
baths serum and placed in forms, where it continues to release serum thanks to pressing, 
which also confers compactness and its shape of the cheese. 
Finally, after the dry salting (repeated several times depending on the type of cheese), the 
obtained shape is matured for varying periods. In this stage are processed carbohydrates, 
proteins and lipids for the enzymes action. The curing times depends on the type of product 
required: can be a few days for fresh and soft cheese up to several years for the more mature 
cheese. (Kapoor and Metzger, 2008). 
 
 
Fig. 1.3. Process flow in production of hard and semi-hard cheese 
(http://www.dairyprocessinghandbook.com/chapter/cheese). 
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RICOTTA CHEESE 
Technology of ricotta cheese production take place through coagulation and precipitation of 
the whey proteins encouraged by acid environment. For this purpose it is, however, necessary 
to reach very high temperatures and over 85°C. Precipitation also involves cheese whey fat 
and lactose. With the traditional manufacturing, ricotta cheese is obtained from sweet whey, 
and excessive acidification would led to the precipitation of whey proteins before time. Whey 
heating occurs generally in the same tanks where cheese is made; it is quite common to add 
whole milk with percentages ranging from 5% to 25% of the total volume of the whey. This 
milk is added when the temperature reaches 60-70°C, and heating follow up to 80-90°C. 
Towards the end of the heating is added an acid whey, residue from previous processes, in 
order to lower the pH; the same result can be obtained with addition of citric acid, lactic acid 
or other acidifying agents. These acids are mixed when it reaches the minimum coagulation 
temperature, because a preliminary insertion may create serious damage to the coagulum with 
a not homogeneous precipitation. When whey proteins precipitate, incorporate air and steam, 
coagulating into a gelatinous mass that tends to surface. The clot is allowed to emerge and 
consolidate for about 5 minutes, suspending the heating simultaneously; subsequently starts 
the recovery of ricotta, which is placed in perforated plastic tanks in order to eliminate the 
liquid part. In many cases in the boiler is added salt, which functions both as a coagulation 
promoter that as real ingredient, to confer to the ricotta a stronger flavour. The addition of salt 
is normally approximately between 0.5% and 1.5% of the final weight. Consequently the 
product is left to dry for a few hours in a cool place and then sold immediately or, in industrial 
plants, subjected to packaging which allows longer storage (Salvatori del Prato, 1998). 
 
1.1.2 Dairy industry by-product: Cheese Whey and Ricotta Cheese Whey 
Dairy industry contributes significantly to the production of liquid waste with a high organic 
load. In 2012 in European Union countries they were produced 90.7 million tons. Italy is the 
third European cheese producer after Germany and France, with an annual output of 1.2 
million tons. in 2012 (http://www.dairyindustries.com/). 
 
CHEESE WHEY 
Cheese production processes originate two main liquid waste streams: cheese whey and water 
wastewater resulting from cooling and cleaning of pipes, tanks etc .. Of these, cheese whey, 
aqueous fraction which is formed during the coagulation of the milk casein in cheese 
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manufacture, is considered the most problematic for its high values of biological (BOD) and 
chemical (COD) oxygen demand. The average specific production is about 0.9 L per litre of 
processed milk or per kilogram of cheese produced. Appropriate management of whey is 
necessary as consequent of the direct discharge prohibitions on land or into water bodies. 
(Guimarães et al., 2010). 
Cheese whey world production of serum in 2008 was over 160 million tons per year, 
estimated at 9 times the production of cheese, and shows an annual growth rate of 1-2%; in 
2010 the World serum production is over 180 million tons per year (estimated production of 
cheese in 9 times), and shows an annual growth rate of about 3-4% (Guimarães et al., 2010). 
In Italy whey production is estimated in about six million tonnes per year (Castilli, 2011).  
Formerly, about 50% of the product cheese whey was disposed as wastewater by subjecting it 
to purification. The companies were therefore subject to the legal regulations relating to non-
hazardous waste: temporary storage in refrigerated tanks, MUD, forms, loading-unloading 
registers. The situation has changed since the entry into force of Legislative Decree no. 
4/2008, which transposition of Community Directive 2008/98 / EC, went to change the 
Legislative Decree no. 152/06 introducing into Italian law the definition of by-product 
(Legislative Decree 152/06 article 183 paragraphs 1 letter. N): 
"A substance or object resulting from a production process, which primary aim is not the 
production of that item, it can’t be considered as waste in accordance with Article 3, 
paragraph 1, but as by-product only if the following conditions are met: 
a) it is certain that the substance or object will be further used; 
b) the substance or object can be used directly without any further processing other than 
normal industrial practice; 
c) the substance or object is produced as an integral part of a production process and 
d) further use is lawful, that is the substance or object satisfies, for the specific use, all 
relevant requirements concerning the products and the protection of health and the 
environment and will not lead to overall adverse environmental or human health. "  
In the same article, paragraph 1, letter. A, there is the definition of waste, already reported in 
the previous chapter: 
"Any substance or object in Annex A (categories of waste - Q8 residues from industrial 
processes) Part Four of this decree, and which the holder discards or intends or is required to 
discard" 
So the by-product is not and should not be considered a waste. 
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Cheese whey contains about 50% of the total solids of the milk origin, and its major 
components are lactose (44-52 g/L), proteins (6-8 g/L) and mineral salts (4-9 g/L) (Aktas et 
al., 2006). The type and the composition of whey mainly depend on the technique of process 
used for removing casein from milk. There are two main varieties of whey, derived from 
different technologies (Table 1.3) (Kosseva et al., 2009): 
 sweet whey, which is derived from the production of pressed cheeses and cooked 
pasta, cheese, and casein obtained by the action of rennet. One litre of this whey 
contains 65 g of dry residue, to which 48 g of lactose, 8 g protein, 7 g of salt and about 
1 g of fat, pH 6-7. 
 acid whey, which is a by-product of the fresh paste cheeses, soft and lactic casein 
production. The acidification of the milk causes increased demineralization of the 
curd; consequently this serum is characterized by a higher mineral content of the 
sweet whey and lower pH if the coagulation rennet-induced casein occurs at a pH of 
about 6.5, the whey obtained is called sweet whey; the acid whey instead results from 
a process that uses fermentation or addition of organic or mineral acids to the 
coagulation of casein and which occurs at pH less than 5 (Adrian et al., 2009). 
 
 
Table 1.3. Typical composition for sweet and acid whey (Kosseva et al., 2009). 
 
Because of its high level of organic substances, mainly lactose, the whey has a high BOD 
(Biological Oxygen Demand), about 30-60 g/L, depending on the cheese-making process 
used and an average value of COD (chemical oxygen demand) between 60 and 80 g/L. The 
recovery of protein reduces the COD of the serum of only about 10 g/L (Guimarães et al., 
2010). Disposal treatment of whey is very costly for companies, so development of integral 
process for employing cheese whey as substrate for production of high- value added product, 
represent an important alternative, despite strong limitations due to storage and transport 
costs, related to limited lactose amount (Manzoni, 2006). A large part of treated whey is dried 
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to produce whey powder, which is commonly used as animal feed but even in small amounts 
in human food, for example in ice cream, cakes, milk derivatives, etc. Another important 
application of the cheese whey is the use of lactose contained in it as substrate for the 
production of compounds of value through fermentation: the classic examples are ethanol and 
single cell proteins (SCP) obtained from bioprocesses with yeasts, but may also include the 
production of biogas, organic acids, amino acids, vitamins, polysaccharides, oils, enzymes 
and other compounds (Guimarães et al., 2010).  
 
RICOTTA CHEESE WHEY 
Ricotta cheese whey (RCW) is a dairy by-product from ricotta cheese production process, 
after flocculation of soluble whey proteins as a consequent of acidification and heating of the 
cheese whey, which is widely product in Europe and especially in the Mediterranean area 
with 1.0 Mt per year only in Italy (Sansonetti et al., 2009). Because of lactose concentration 
between 4 and 5% (w/w), BOD of 50 g/L and COD of 80 g/L,  RCW presents pollution 
problems and its disposable is an added cost for dairy industry. Its low protein concentration 
makes it unless for protein valorisation applications (like for cheese whey), and at the present 
it is employing just for cattle feed (Sansonetti et al, 2010). RCW valorisation can be achieved 
by its employment as a carbon source in biotechnological applications for lactose 
bioconversion into valuable product like lactic acid, ethanol and LBA (Secchi et al., 2012). 
 
1.1.3 Lactose: problems and opportunities 
Lactose, the only milk sugar, is a disaccharide consisting of a molecule of glucose and one of 
galactose, linked together by a glycosidic bond β 1-4. In aqueous solution at 20°C, lactose 
exists in two isomeric forms: for 62.7% as β-lactose and for 37.3% as α-lactose. The content 
of lactose in milk varies in different mammal: for example, cow's milk contains about 4.9% 
and the human milk approximately 6.7% lactose (Kuusisto et al., 2007). In fermented cow's 
milk, lactose content is about a third of which that is present in the milk, due to the lactose 
conversion work by lactic acid bacteria. During cheese production nearly all the lactose in the 
milk is transferred in whey. The lactose content in cheese whey is about 4.8 g per 100mL (G. 
Schaafsma, 2008). It is a crystalline solid, colour less, reductant and slightly soluble in water: 
its solubility limit is 22 g per 100 g of water at 25°C (Guimarães et al., 2010). The lactose 
plays a slight sweetening effect on the milk, even if much reduced compared to sucrose that is 
6 times more sweetener. Lactose is hydrolysed in the two monomers which in this way may 
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be used by lactic acid bacteria to produce lactic acid, responsible for the acidification of the 
milk (Gigliotti and Verga, 2007). 
Lactose is therefore an important product of cheese and ricotta cheese manufacture, whose 
production was estimated at 1.2 million tons a year, and whose global market will reach 1.4 
billion dollars by 2015 (Gutiérrez et al., 2012). It is mainly used as an ingredient in food, 
drink and sweet products, and it has been widely used as a diluents in pills and as a support 
drug for pharmaceutical industry. Nevertheless, its use is limited in many applications due to 
its low sweetness and solubility, and for the intolerance of the population; finally only 
a small amount of lactose is used as a raw material for fine chemicals productions (Gutiérrez 
et al., 2012). 
From the feed stock milk, skimmed whey is generated after casein precipitation and lipids 
removal. After removing 80% of water from the skimmed whey, the concentrate whey is ultra 
filtrated to generate whey permeate (the lactose fraction) and whey retentate (the protein 
fraction with considerable lactose residues). Certain components of the retentate such as 
lactoalbumin and lactoferrin fractions are of pharmaceutical interest, instead whey permeate 
(which contains 81% of the original lactose in milk) is a potential carbon source (Povolo et 
al., 2010). Lactose can easily be separated from natural matrix (milk or whey) and purified for 
food (baby food, cakes, biscuits, chocolate, soups and sauces) feed and pharmaceutical 
applications; but it can also be used as a precursor of lactose-derived bioactive substances 
(Schaafsma, 2008). 
A lot of studies were focused on the opportunity to valorised lactose as a source for producing 
polyhydroxyalkanoates (Pantazaki et al., 2009; Povolo et al., 2010), ethanol (Sansonetti et al., 
2009; Guimarães et al., 2010), hydrogen, lactic acid (Secchi et al., 2012), and the conversion 
into lactobionic acid has been investigated as a new and promising strategy (Alonso et al., 
2013).  Lactose can be used directly by lactose-consuming microorganisms or pre-hydrolysed 
for lactose-negative microorganisms, and its employment as a renewable and cheap feedstock 
for fermentative processes to obtain value-added products is an interesting alternative to 
chemical synthesis processes, within the general framework of the rapid advances in 
microbial biotechnology (Guimarães et al., 2010). 
 
1.2 LACTOBIONIC ACID  
LactoBionic Acid LBA (molecular weigh: 358.3 g/mol and pKa: 3.6) is a versatile complex 
polyhydroxy acid (C12H22O12) composed of a galactose molecule linked to a gluconic acid  
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unit by an ether-like linkage (Table.1.4). Notable is its high water solubility; calcium salt of 
LBA is 40000 times higher water soluble than calcium carbonate and 10 times higher than 
calcium lactate (Nakano et al., 2010). 
 
 
Table 1.4. Physiochemical properties of LBA (Alonso et al., 2013). 
 
It is obtained via lactose oxidation and presents a lot of interesting application in food, 
cosmetics, pharmaceutics and chemical industries thanks to its antioxidants, chelating and 
humectants properties (Gutiérrez et al., 2012).  
Recently the biotechnological  industry has moved from commodity bulk carboxylic acids to 
value-added organic acids which display outstanding applications, and LBA has emerged as a 
promising and interesting substance, with a significant improvement of the commercial rate in 
recent years (Alonso et al., 2013). Actually LBA market is between 15000 and 17000 tonnes 
per year with an annual rate of about 5% growth (Gutiérrez et al., 2012). The majors LBA 
industrial manufacturers are Solvay (Germany), FrieslandCampina Domo (Netherlands), 
Sandoz (Germany), Reliable Biopharmaceutical Corporation (USA) and the US Dairy 
Ingredient Company (USA). LBA is increasingly taking on a predominant role in the market, 
so that companies like Solvay opened a plant in Germany in the late 1990s with the aim of 
achieving an annual production of 1000 t. (Alonso et al., 2013).  
 
1.2.1 Properties 
Thanks to its particular chemical structure with a lot of hydroxyl groups, LBA presents 
antioxidant, ion-chelating and humectants properties which make it biodegradable, 
biocompatible and non-cytotoxic (Selim et al., 2009; Alonso et al., 2013; Tasic-Kostov et al., 
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2012). It is a hygroscopic compound with a high water solubility of its salts and forms gels 
contain about 14% of water with atmospheric moisture (Nakano et al., 2010; Gutiérrez et al., 
2012). Also it presents pH-reducing effects, combining with sweet taste (2 kcal/g) and 
competes with lactose for binding to intestinal beta galactosidase. LBA presents a strong 
mineral-complexing properties and a good resistant to digestive enzymes, exercising prebiotic 
effects (Schaafsma, 2008).  
 
1.2.2 Use and applications 
LBA excellent physiochemical properties make it suitable for a lots of interesting commercial 
applications, as can be resume in Fig. 1.7.  
 
 
Fig. 1.4. Summary of LBA applications (Alonso et al., 2013) 
 
LBA is widely used in pharmaceutical industry, as a ligand molecule in drug-delivery 
systems, thanks to its unique properties such as biocompatibility, biodegradability and ion-
chelating ability (Alonso et al., 2013). According to the development of novel therapeutic 
treatments based on hepatic-targeted drug delivery system for clinical therapy (i.e. 
chemotherapy), LBA-based drug delivery system are able to target efficaciously hepatocytes; 
in fact LBA is a successfully ligands for asialoglycoprotein receptors (ASGPR) located on 
hepatocytes (hepatocytes targeted cells), and these receptors are the favoured targets for 
potential hepatic interventions (Lin et al., 2009).  Bio-functionalization of gene carriers with 
LBA may improve their hepatocyte specificity; for example chitosan has been widely 
investigated as a drug delivery carrier and gene delivery vector for its several biological 
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advantages (biodegradability and low toxicity), and LBA-coupled chitosan (GC) binds to 
hepatocytes presents better efficacy (Fig. 1.8) (Kim et al., 2006). 
 
 
Fig. 1.5. Synthesis scheme of GC  (Kim et al., 2006) 
 
It can also be used as a platform for chemical biosynthesis of antioxidants carriers (Ortial et 
al., 2006) or as a carrier shielding from enzymatic attack for peptides  and proteins delivery 
(Meng et al., 2012).  
Another LBA application for novel diagnostic tools in biomedicine, is as coating material 
surface of nanoparticles used for biomedical applications such as biodetection, cancer 
therapies, magnetic resonance imaging or bio-labeling, contributes to physicochemical 
stability (Chung et al., 2002; Fa et al., 2010). In bioimaging applications, for example, LBA 
bound to nanoparticles fluorescent has showed an efficient and promising means of survey in 
the discovery and identification of liver cancer cells in a complex cellular matrix such as 
blood. The organic nanoparticles functionalizing have presented several advantages compared 
to traditional therapeutic tools (Fig. 1.9), such as biodegradability, biocompatibility, 
sensitivity detection, solubility in water, long-term stability and low cytotoxicity (Kekkonen 
et al., 2009; Selim et al., 2007).  
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Fig. 1.6. Synthesis of lactobionic acid-grafted magnetite nanoparticles (Selim et al., 2007) 
 
In tissue engineering, aimed at developing new fabrics functional to replace, repair or 
regenerate damaged tissues or organs, LBA does not contribute directly to the growth of 
tissues and biomaterials, but it can facilitate the attachment and the entrapment of 
hepatocytes: LBA is entrenched in a polymer matrix through functional groups such as the 
galactose molecule, enhancing functional capacities and biocompatibility of tissue 
engineering materials such as scaffolds generated from natural polymers or synthetic 
polyesters. These form the links that are able to increase the adhesion and aggregation of 
hepatocytes and to maintain long term specific functions of the liver and the mechanical 
stability (Kim et al., 2008; Kim et al., 2011). Furthermore, LBA addition has  a key role in 
antibiotic formulations like erythromycin for treating bacteraemia and in formulation 
containing chlorhexidine as antiseptic substance,  increasing their water solubility and 
stability (Nakano et al., 2010). A recent European Patent from Cavallo et al. (2012) was 
concerned on the possibility to employ LBA as a therapeutic agent for treatment of corneal 
edema and inflammation, overcoming the problems exhibited by conventional hyperosmotic 
current formulation (Cavallo et al., 2012). 
LBA also has an important role in preservative solutions for organ storage avoiding oxidative 
damage, because of its metal ions chelating capacity (Hart et al., 2002), and in anticoagulant 
and antithrombotic drugs (Gutiérrez et al., 2012). Efficacy organ preservation is based on the 
minimizing the metabolic rate of the organ and the inactivation of most enzyme reactions 
protects the cell and drops the use of high-energy purine nucleotides. The  University of 
Wisconsin solution (UW solution), called Via Span or Belzer solution as commercial name, 
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was development by Belzer et al. (1992) for cold storage of organs before transplantation and 
actually it has been used worldwide thanks to its efficiently prevention of ischemia and 
reperfusion injury, playing a key role in organic cytoprotection and viability prior to 
transplantation. LBA is an important component of UW solution, acting as a cell impermeant 
agent during the organs cold storage, providing osmotic support and preventing cell swelling; 
it also has antioxidant effect, scavenging free hydroxyl radicals generated in the medium as 
well as cryptic inhibitor of matrix metalloproteinases (Belzer et al., 1992; Hart et al., 2002; 
Alonso et al., 2013).        
In cosmetics products, due to its anti-aging and regenerative skin-care effects added to a trong 
anti-oxidant effect, it represents an important niche in the market as new and essential 
component in formulations for skin care, generating US sales of about $1 billion. Currently, 
LBA is used in cosmetic industry as a key component in the new anti-aging products and like 
keratinization agent formulations cosmeceutical; in fact, the acid inhibits the collapse of the 
enzyme matrix metalloproteinase due to metal chelation, thus reducing the presence of 
photoaging and wrinkles. LBA is also used in therapeutic treatments for skin diseases such as 
atopic dermatitis and rosacea, or even anti-acne treatments (Tasic-Kostov et al., 2012). 
Recently, polyhydroxyacids such LBA have offered similar therapeutic effect of alpha-
hydroxyacids reducing irritant effects, suggesting the possibility of an employment for 
sensitive skin treatments. In addition to LBA employment as an anti-aging and keratinization 
agent in cosmeceutical formulations, it also exhibits moisturizing, exfoliative and humectant 
properties, which increase its commercial role in cosmetic field (Green et al., 2008; Yu and 
Van Scott, 2004). 
 
 
Fig. 1.7. Eyelid skin before (A) and after (B) 12 weeks of treatment with lactobionic acid 8% 
Diminished periocular fine lines and improved eyelid skin texture are shown (Green et al., 
2008). 
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In chemical applications, thanks to its iron-chelating properties and emulsifying properties,  
LBA contribution is significant for the production of biodegradable detergents and sugar-
based surfactants (Oskarsson et al., 2007) improving physical-chemical properties reducing 
environmental impact. Others fundamental applications of LBA in chemical products are as 
an active element in a novel antibacterial agent composition, which confers excellent 
preservation stability on consumers goods (Araki et al., 2006), and as a building block for the 
biocatalytic synthesis of novel polymers, as reported for example in Fig. 1.11, where GL was 
used as non-derivatized co-monomer, but other derivatives of sugars (like LBA) could were 
also appropriate (Kakasi-Zsurka et al., 2011).   
 
 
Fig. 1.8. Biocatalytic route for the synthesis of sugar-containing copolymers of 3-HBA based 
on renewable resources (Kakasi-Zsurka et al., 2011). 
 
In food industry  LBA has received growing attention as food additive: for its antioxidant, 
stabilizer and gelling effect in dessert products; as acidifier agent in fermented milk products; 
and as aging inhibitor for bread. Additionally LBA may stimulate calcium absorption 
avoiding health disorders associated to this mineral shortage. In particular LBA may stimulate 
intestinal Ca
2+
 or mineral absorption, exerting health-promoting influence for preventing and 
treating health disorders connected with calcium insufficiency, and recently were appeared on 
commercial market dairy beverages containing this polyhydroxy bionic acid as functional 
ingredient  (Nielsen and Hoeier, 2009). Furthermore LBA was studied as a feed additive for 
laying hens reinforcing eggshell qualities by boosting calcium absorption (Kimura, 2006). 
Recently a lot of novel dairy-making processes were performed including LBA as a key 
element, provides extra-functional properties and sensory attributes through the reduction of 
undesirable Maillard browning reactions in cooking products (Merrill and Singh, 2011). Anti-
oxidant effect and water-holding capacity of LBA were recently investigated in meat products 
submitted to thawing and cooking processes, reducing the water loss upon freezing (Nielsen, 
2009). The importance of LBA as a functional food have been demonstrated by its approval 
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as a food additive by FDA in the USA, thanks to its prebiotic effects, low-calorie sweetener (2 
kcal/g), gelling, stabilizing and aging inhibitor effects. LBA was also described as an active 
bifidus promoter molecule for different functional food and beverages (Alonso et al., 2013; 
Schaafsma, 2008; Oe and Kimura, 2011). Kiryu et al. (2009) isolated LBA from “Caspian Sea 
yogurt”, estimating an indivual intake of 0.5-1.0 g of LBA per year when consuming 100 g of 
the yogurt per day (Kiryu ert al., 2009). 
 
1.2.3 Production methods 
Conversion of lactose to LBA proceeds through the oxidation of free aldehyde group of 
glucose, in lactose molecule, to carboxylic acid group. LBA was firstly synthetized by Fisher 
and Meyer (1889) through a chemical oxidation of lactose with bromine (Fisher and Meyer, 
1889). Nevertheless currently chemical procedures (electrochemical and heterogeneous 
catalytic oxidations) involving refined-lactose oxidation (Fig. 1.20) and harmful and costly 
catalysts with undesirable side-reaction products (Yang and Montgomery, 2005; Kuusisto et 
al., 2007; Tokarev et al., 2009) have been shelved  in favour of more interesting and 
sustainable biocatalytic processes, that lead to LBA through lactobiono-δ-lactone intermediate 
(Fig. 1.21). They comprises enzymatic synthesis, expensive processes due to the presence of 
redox mediators and cofactors need to be regenerated (Maischberger et al., 2008; Van Hecke 
et al., 2009), and microbial production employing bacteria strain able to oxidize lactose in 
their metabolism producing LBA.  
 
 
Fig. 1.9. Schematic oxidation of lactose to LBA (Gutiérrez et al., 2012). 
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    Fig. 1.10. Schematic biocatalytic oxidation of lactose to LBA (Gutiérrez et al., 2012). 
 
ELECTROCHEMICAL OXIDATIONS 
Electrochemical oxidation of lactose, separating calcium lactobionate from the products, was 
development by Isbell (1934) in an US Patent, in the presence of calcium carbonate and a 
bromide, separating the calcium lactobionate first in the form of a crystalline calcium bromide 
double salt and then treating this with an excess of lime to cause the precipitation of a basic 
calcium lactobionate from which the normal salt is prepared by carbonation (Isbell, 1934). 
This procedure led to an aqueous solution and acid isolate in a solid form was very difficult, 
hindering an efficient industrial implementation. So Magariello and Islip (1956) improved this 
process for production of high quantity of LBA via electrolytic lactose oxidation using 
graphite electrodes subjecting lactose to electrolysis in an aqueous solution in the presence of 
iodine and bromine catalysts, and an alkaline substance to maintain the pH above 5.2, 
avoiding decomposition of any unoxidized lactose. After this the crude electrolysis reaction 
solution was treated with cation and anion exchange resins to remove inorganic ions, and 
spray-dried  the effluent aqueous lactobionic acid solution to convert the lactobionic acid 
therein into a dry mixture of acid and δ-lactone with a global yield of about 98% of LBA 
(Magariello and Islip, 1956). Subsequently different studies were carried out by Druliolle’s 
group demonstrating how high yields and selectivity rates were achieved employing noble 
metal electrodes (platinum, platinum-modified and gold electrodes) in alkaline media 
(Druliolle et al., 1994; Druliolle et al., 1995; Druliolle et al., 1997), but the high cost of the 
process obstacle global interesting for this procedure (Gutiérrez et al., 2012).      
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HETEROGENEOUS CATALYTIC OXIDATIONS 
It is a very promising field for the possibility of integration with others transformation 
technologies (Gutiérrez et al., 2012). LBA is the main product but, as reported in Fig. 1.22, 
lactulose and 2-keto lactobionic acid are undesired by-products of the reaction, depending on 
different operating conditions; metal (platinum or palladium  modified with bismuth), pH 
(between 8.0 and 9.0, since isomerization of lactose to lactulose is greatly favoured), pressure 
(atmospheric pressure), temperature (from 50 to 70°C) and O2 concentration presents 
importance influence on LBA selectivity. Lactose catalytic oxidation on palladium an 
bismuth-palladium, for LBA production, was firstly investigated by Hendriks, Kuster and 
Marin (1990), where Bi promotion of a commercial Pd-C catalyst resulted in 100% selectivity 
to sodium lactobionate up to conversions of 95% in the pH range 7–10 and at temperatures up 
to 333 K (Hendriks et al., 1990). Since then, different studies concerning the improvement of 
lactose oxidations on palladium and bismuth-promoted palladium, have been investigated 
(Gutiérrez et al., 2011), but the problems connected with the poisoning and deactivation of the 
catalysts by oxygen (Belkacemi et al., 2007) and the limited opportunity to use bismuth for 
the food and pharmaceutical productions, for its tendency to leaching, led to shift attention on 
more stable catalysts, such as supported gold catalysts.  Particularly is the case of Au/CeO2, 
where the consecutive oxidation step to 2-keto-lactobionic acid did not take place at all, 
resulting in 100% conversion and 99% selectivity for lactobionic acid over 3 h reaction time, 
while on Pd/C catalyst 89% selectivity at 93% lactose conversion was achieved (Climent et 
al., 2011). Furthermore, according with others studies, supporting gold nanoparticle on Al2O3, 
TiO2, and CeO2 led to over than 80% of conversions with selectivity up to 95%, using Au 
loadings in the range of 0.4-2.0% (Kuusisto et al., 2007).  
Gold catalysts supported on silica materials mesoporous were synthetized by Gutiérrez et al., 
(2012) , which made possible to achieve 100% of the conversion lactose and 100% selectivity 
for LBA after only 10 min reaction (Gutiérrez et al., 2012). Despite the interesting LBA yield 
results obtained, chemical production employing metal catalysts also presents negative 
aspects related to security of the substances used and to the increasing interests of the 
consumer, which tends to prefer to source products "bio" (Alonso et al., 2013). 
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Fig. 1.11. Schematic catalytic oxidation of lactose to LBA under alkaline conditions 
(Gutiérrez et al., 2012). 
 
BIOCATALYTIC OXIDATION: ENZYMATIC SYNTHESIS AND   
MICROBIAL PRODUCTION 
LBA biocatalytic production approach involves  lactose oxidation of lactose thanks to specific 
enzymes or microorganisms used as biocatalysts. The general scheme of reaction (Fig. 1.23) 
leads to the formation of an intermediate product, the lactobiono-δ-lactone, which is 
subsequently hydrolysed to lactobionic acid. Usually the process takes place in medium 
temperatures (25-50 ° C) and, since the pH must be maintained constant by addition of bases 
of Na-, Ca- or K-, the final product can be LBA or a salt (Gutiérrez et al., 2012). From an 
industrial point of view, the yield obtained through any biotechnological approach must 
be at least 50-100 g/L in order to achieve product concentrations that are comparable to those 
obtained with chemical processes (S. Alonso et al., 2013), and a comparison of production 
costs is essential to evaluate the advantage of biotechnology. 
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Fig. 1.12. Biocatalytic oxidation of lactose molecule to LBA in bacteria strains (Alonso et al., 
2013). 
 
 Enzymatic production of  LBA proceeds through refined lactose oxidation 
employing enzymes (such as oxidoreductases) (Fig. 1.24).  
  
 
Fig. 1.13. Schematic processes for LBA production through enzymatic synthesis (Alonso et 
al., 2013) 
 
Cellobiose dehydrogenase (CDH) is an extracellular hemoflavoenzyme produced by 
wood-degrading fungi (i.e. S. rolfsii), that oxidise lactose to the corresponding 
lactones. A combination of an electron acceptor, 2-2-azinobis-(3-ehtylbenzothiazoline-
6-sulfonate) (ABTS), and a regenerating enzyme (laccase) was studied by Dhariwal et 
al. (2006) in an electrochemical process using electricity instead oxygen as a final 
acceptor of electrons, for the oxidation of lactose to LBA. This biocatalytic system led 
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to achieved 1.8g/L*h of LBA in 25 ml electrolysis cell with ABTS as the redox 
mediator, removing the need of the second enzyme (laccase) in the regeneration 
system. This new system has the advantage of operating at the optimum pH value for 
CDH activity and of controlling mediator concentration, but the lower LBA titres 
obtained, in comparison with others biocatalytic approaches represented a drawback to 
an industrial implementation (Dhariwal et al., 2006). 
A biocatalytic approach for LBA production from refined lactose by CDH, with 
ABTS as electron acceptor and laccase as regenerating enzyme, was also carried out 
by Baminger et al. (2001). A novel concept of enzymatic regeneration of electron 
acceptors was introduced (Fig. 1.25). A complete lactose bioconversion with a LBA 
volumetric productivity of 18 g/L*h in 50-mL batch reactor with DCIP (2.6-
dichloroindophenol)  as redox mediator (Baminger et al., 2001). 
 
 
Fig. 1.14. Continuous, laccase-catalyzed regeneration of electron acceptors ( redox mediators) 
that are employed in oxidation reactions of flavoproteins (Baminger et al., 2001). 
  
Inactivation of the enzymatic system with growing of dissolved oxygen is a drawback 
of enzymatic biocatalytic approach for lactose oxidation to LBA by CDH and laccase, 
and Ludwing et al. (2004) were displayed the need to remove redox mediators from 
the system after biocatalysis by means of adsorption due to their toxicity. In the 
biotransformation system, featuring the continuous laccase-catalyzed regeneration of 
the electron acceptors, 7g/L*h of LBA were achieved after 10 h with complete lactose 
bioconversion (Ludwig et al., 2004). 
The beneficial effect of membrane facilitated, diffusive (bubble-less) oxygenation on 
enzyme stability through prevention of enzyme inactivation at the gas/liquid interface 
has been observed by several authors for various enzymatic oxidation reactions (Van 
Hecke et al., 2009). These authors also performed a 20L-reactor to model and study 
this process using the dynamic membrane aeration (DMA) reactor coupled to an 
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ultrafiltration module for discontinuous and continuous operation; the conversion was 
catalyzed by an enzyme cascade consisting of cellobiose dehydrogenase as 
synthesizing enzyme and laccase as regenerating enzyme coupled by a redox 
mediator, achieved 3.21 g/L*h fo LBA with 97% of lactose conversion yield (Van 
Hecke et al., 2011). 
Excessive lactose from a transgalactosylation process for galacto-oligosaccharides 
(GalOS)production was removed efficiently through a biocatalytic approach coupled 
with a chromatographic steps: lactose was firstly oxidized to LBA using CDH, and 
removed by ion-exchange and size-exclusion chromatography. Two different CDH, 
originated from S.rolfsii and M.thermophilum were compared with respect to their 
applicability for this process: CDH from S.rolfsii showed higher specificity for lactose 
substrate, ranging from 6 to 16 g/L*h of product LBA, with 96-100% lactose 
bioconversion  (Maischberger et al., 2008). 
The use of a glucose-fructose oxidoreductase (GFOR) enzyme from Zymomonas 
mobilis has been employed as a biocatalyst to oxidize lactose and fructose, for LBA 
and sorbitol synthesis under batch, fed-batch and continuous conditions. The apparent 
Km of GFOR for lactose is 1.2±0.1 M, which corresponds to a 80-fold reduction of 
affinity for substrate binding, relative to the physiological substrate glucose. Thanks to 
the presence of reaction stabilizers, the GFOR presented constant biocatalytic activity 
up to 150 h, that led to a productivity of  4.6 g/L*h of LBA in continuous 
ultrafiltration membrane reactors (1.8-fold higher than batch conditions) (Satory et al., 
1997). 
Oxidation of lactose to LBA was also studied by Nordkvist et al. (2007) through 
Microdochium nivale carbohydrate oxidase activity, considering as safe for use in the 
food industry. This oxidise, contained one FAD per protein with relative molecular 
mass of 55000 Da, is able to oxidize several mono-, oligo- and polymeric saccharides 
and transfer their electrons to molecular oxygen, producing peroxide hydrogen which 
can be removed through catalase addition. This approach allows to achieve a LBA 
volumetric productivity of 4.9 g/L*h with 98% yield in batch enzymatic reaction 
performed at 38°C and 0.2 Lpm continuous gas supply (mixture N2/O2); but after 6h 
the system has showed a decrease in productive efficiency due to the inactivation of 
the enzyme resulting from the addition of NaOH for maintained constant pH 6.4  
(Nordkvist et al., 2007) 
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A pilot-scale reactor (1L-STR) of 600L working volume, using a rotary jet head for 
improving mixing and mass transfer, led to an higher LBA titre (49 g/L after 12h), 
avoiding oxidases enzymes deactivations and demonstrating the scalable potential of 
the biocatalytic process  (Fig. 1.26) (Hua et al., 2007). 
 
 
Fig. 1.15. Experimental set-up of the rotary jet head system (Hua et al., 2007). 
 
A complete lactose (10-20% w/v) conversion to calcium lactobionate was carried out 
in a 500 mL reactor under aeration, agitation and pH 5.5, with a lactose-oxidizing 
enzyme obtained from culture supernatant  of a fungal strain of Paraconiothyrium sp. 
KD-3 at 40°C; from 100-150 g/L of lactose a rate of 9-11 g/L*h were achieved after 
10-20 h  (Murakami et al., 2008). 
An approach with immobilized purified lactose-oxidizing enzyme from 
Paraconiothyrium sp. KD-3 on cation exchange resin allowed to oxidized up to 185 
g/L of lactose, despite the efficient of the process after different batch process slow 
down for the formation of hydrogen peroxide during the reaction, which inactivated 
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the immobilized enzymes (Nakano et al., 2010).  Hydrogen peroxide, which was 
formed in concomitant to lactose oxidation by carbohydrate oxidases (from 
Microdochium nivale ) or lactose-oxidizing enzymes (from Paraconiothyrium sp. KD-
3) as a consequent of oxygen employment as electron acceptor, has an inactivated 
effect on enzymes and this drawback can be overcome by addition of catalase. Also 
glu-cooligosaccharide oxidase (GOOX) from Acremonium strictum was also tested as 
an efficient sugar oxidizing enzyme which displays a high optimum at pH 10 (Lee et 
al., 2005).  
 
 
Table 1.5. Substrates specificity of native GOOX (Lee et al., 2005). 
 
Despite high LBA productivity and selectivity and simplified downstream processes,  
the costs of the process, connected with redox mediator, cofactor regeneration and 
arduous upstream steps, and limitations related to the enzymes activity loss during the 
process (Alonso et al., 2013). 
  
 LBA microbial production strains was firstly reported by Stodola and Lockwood in 
the middle of 19th century; they screened Pseudomonas species and identified 
Pseudomonas graveolens 14 as the best producer of LBA from lactose oxidation (75% 
yield after 165 hours in shake flasks) (Stodola and Lockwood, 1947). Several 
microorganisms have been investigated for LBA production (Pseudomonas 
fluorescens, Pseudomonas myxogenes, Burkholderia cepacia, Acetobacter orientalis, 
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Streptococcus lactis, Zymomonas mobilis) but the process proceeds slowly with low 
yield (Fig 1.27; 1.28) (Alonso et al., 2013).  
 
 
Fig. 1.16. Reaction schemes of a bi-substrate enzymatic system carried out by glucose-
fructose oxidoreductase in Zymomonas mobilis for LBA and sorbitolo productions  (Alonso et 
al., 2011). 
 
 
Fig. 1.17. Schematic process for LBA production through microbial activity (Alonso et al., 
2011). 
 
Miyake and Sato also reported aldonic acids production from sugars through a two-    
stages process, comprising a first growth phase of Pseudomonas species and a second    
enzymatic synthesis of the interested compounds by permeabilized cells. 
Pseudomonas species are the ideal platforms for lactose oxidation producing LBA, 
thanks to the absence of the genes encoding the β-galactosidase enzyme, which divide 
lactose molecule in glucose and galactose components (Miyake and Sato; 1975). In 
Pseudomonas species LBA is formed via lactose oxidation pathway, in which a 
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membrane-bound dehydrogenase system catalyzes this single biotransformation (Fig. 
1.23); a lactose dehydrogenase enzyme first catalyzes lactose oxidation t a lactone 
intermediate (lactobiono-δ-lactone) which is consequently hydrolyzed into LBA by a 
lactonase enzyme. Lactose dehydrogenase does not use oxygen as a direct acceptor of 
electrons and presents an optimum pH at 5.6 with Km value for lactose of about 11 
mM; while lactonase presents an optimum pH at 6.5-6.7, with Km of 20 mM, although 
the specific enzyme activities vary with growth conditions (Nishizuka and Hayaishi, 
1962).  
According to Vakil and Shahani (1969) lactobionate constituted an initial intermediate 
in the lactose metabolism of Streptococcus lactis UN; the lactobionate thus formed 
was further hydrolyzed to gluconate and galactose through enzyme lactobionase (β-
galactosidase) action and then metabolized. During the lactobionate and glucose 
fermentations, the organism produced varying amounts of lactic, formic, and acetic 
acids, carbon dioxide, ethanol and glycerol, and their concentrations were comparable 
to those produced during the lactose fermentation (Vakil and Shahani, 1969). 
LBA production from lactose oxidation by filamentous fungi (Penicillium 
chrysogenum) was investigated by Bucek et al. (1956) in shake-flasks cultures where 
50% of LBA yield was achieved after 120h (Bucek et al., 1956). 
It was observed in the course of a study of the carbohydrate metabolism of the marine 
red alga, Iridophycus flaccidum, that cell-free extracts of this plant had the ability to 
oxidize D-glucose to D-gluconic acid, thanks to carbohydrates with an optimum pH of 
5.0. Further investigation revealed that this preparation will also oxidize several 
reducing disaccharides, like maltose, lactose, and cellobiose, to their corresponding 
aldobionic acids (Bean and Hassid, 1956). Pseudomonas taetrolens is a non-
pathogenic wild-type microorganisms taxonomically belongs to the Pseudomonas 
choloraphis  group (Sugiyama et al., 2005) able to oxidize lactose producing LBA 
with production yields, titres and productivity values comparable with LBA bio-
production carried out by other bacteria strains like Burkholderia cepacia and  
Zymomonas mobilis (Murakami et al., 2002, 2003, 2006; Pedruzzi et al., 2011). 
Alonso et al. (2011, 2012) studied the positive effect of the size of the inoculum in 
order to reduce the onset of the stationary phase, where LBA molecule is obtained, and 
the importance of a pH-shift an high-cell density conditions with the aim of overcome 
drawbacks which limited LBA productivity by P. taetrolens  cells (Alonso et al., 2011, 
2012).  Negative effects on LBA bio-production yield of both high aeration and 
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agitation rates were also investigated; mild agitation rates (350 rpm) increase LBA 
productivity 1.2-fold compared to high agitation rates (1000 rpm) and the best value of 
oxygen supply was 0.5 Lpm. Another important feature of the bio-production of LBA 
by P. taetrolens is the strongly relation with the physiological status of the cells used 
as inocula, like seed culture age and microenvironmental pH. In fact prolonged-time 
seed cultures (>12h), resulting in the presence of lag-phases along with reduced 
fermentation efficiencies in term of LBA productivity; furthermore pH values lower 
than 6.0 led to stressed environmental conditions for the cells physiological response  
(Alonso et al., 2012). All these aspects are very important in order to an industrial 
implantation and scale up processes. 
High-level production of LBA can be obtained by Pseudomonas sp. LS13-1 mutants 
which, under fed-batch fermentation coditions supplemented with 15 g/L of peptone as 
nitrogen source, achieved a LBA titre of 290g/L with 1.87 g/L*h of volumetric 
productivity (Miyamoto et al., 2000). But an industrial implementation with mutant 
strains presents a lot of difficult for their genetic instability. 
Mutant strains of Bulkolderia cepacia (No. 24) exhibited higher lactose-oxidizing 
activity: 5.55 g/L*h in shake flask cultivations, and better performance can be 
obtained through metabolic engineering approach for the identification and 
modification of the target genes directly or indirectly involved in LBA formation 
(Murakami et al., 2002, 2003, 2006).  
The problems connected with the pathogenicity of B. cepacia have overcome through 
biotechnological production of LBA by an acetic acid microorganism, Acetobacter 
orientalis, which was isolated from “Caspian sea yogurt” and oxidized 2-10% of 
lactose at a yield of 97-99% with resting cells, nutrient-rich media and shake flasks 
conditions, thanks its membrane-bound dehydrogenase oxidize monosaccharides and 
disaccharides (Kiryu et al., 2009, 2012). 
Another acetic acid bacteria was investigated by Oe et al. (2008); Gluconobacter 
cerinus UTBC-427 showed strong lactose-oxidizing activity and has been recently 
selected by Unitika (Japan) as microbial platform for LBA industrial bio-production 
under resting cells conditions (Oe et al., 2008; Kimura 2012). 
In addition different studies employed permeabilized cells have been carried out in 
order to achieve higher LBA titres. Zymomonas mobilis is able to produce LBA in a 
bi-substrate system in which lactose oxidation was coupled with the reduction of 
fructose to sorbitol (Fig. 1.27). The two products results from GFOR enzymatic 
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system contained in the permeabilized cells, at pH 6.4 and temperature from 39 to 
45°C, despite the low affinity of GFOR for both lactose and fructose required high 
level of substrate concentration to promote high productivity. High LBA titres (125-
182 g/L) and yields (78-100%) were achieved with permeabilized cells of Z. mobilis 
with 5.8-7.6 g/L*h of production rates. Also the possibility of cells immobilization in 
calcium-alginate beads (with diameter of 1.2 mm) was approached and 14.9 g/L*h 
LBA was achieved, but additional studies should be performed to verify the long-term 
mechanical stability of calcium alginate beads (Malvessi et al., 2013; Pedruzzi et al., 
2011).    
 
Biocatalyst Conversion 
yield (%) 
Selectivity 
for LBA 
(%) 
Reaction 
time 
(min) 
Space-
time yield 
for LBA 
(g/L*h) 
References 
GFOR/GL enzymes     
from Zymomonas 
mobilis ATCC 29191 
⁓85 100 1500-
4500 
5.6 (Borges da 
Silva et al., 
2011; Pedruzzi 
et al., 2011) 
GFOR from 
permeabilized cells of 
Zymomonas Mobilis 
CP4 (ATCC 31821) 
⁓90-95 100 3600 0.8-2.3 (Severo Junior 
2008) 
GFOR from 
Zymomonas mobilis 
DSM 473 
90-95 100 4200 2.6-4.6 (Satory et al., 
1997) 
GFOR from Zymomonas 
mobilis DSM 3580 CDH 
(EC 1.1.99.18) from 
Sclerotium rolfsii 
(SrCDH; 420 U L
-1
) 
Þ laccase (EC 1.10.3.2; 
2030 U L
-1
) 
95-98 100 720 3.1 (Vn Hecke et 
al., 2011) 
CDH (EC 1.1.99.18) 
from Sclerotium rolfsii 
CBS 191.62 þ laccase 
(EC 1.10.3.2) from 
Trametes pubescens 
MB 89 
100 ⁓100 360 - (Van Hecke et 
al., 2009) 
CDH from Sclerotium 
(Athelia) rolfsii 
⁓100 100 600 - (Meischberger 
et al., 2008) 
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CDH from Sclerotium 
rolfsii CBS 191.62 
Þ laccase from Trametes 
pubescens MB 89 
99 100 150 15.9 (Splechtna et 
al. 2001) 
CDH (EC 1.1.99.18) 
from the basidiomycete 
Sclerotium rolfsii   
CBS 191 
100 100 420 3.0 (Van Hecke et 
al., 2009) 
CDH from Athelia 
(Sclerotium) rolfsii 
CBS 191.62 þ laccase 
from Trametes 
pubescens MB 89 
⁓100 100 300-
1350 
3.0-21.0 (Ludwig et al., 
2004) 
CDH from Athelia 
(Sclerotium) rolfsii 
CBS 191.62 þ laccase 
from Trametes 
pubescens 
MB 89 
100 100 150-250 7.2-27.0 (Baminger et 
al., 2001) 
CDH from the 
ascomycete 
Myriococcum 
thermophilum 
100 100 420 3.3 (Van Hecke et 
al., 2009) 
CDH from Myriococcum 
thermophilum 
⁓100 100 600 - (Mainschberger 
et al., 2008) 
CDH from 
Microdochium nivale 
Þ catalase (Catazyme
®
  
25 L from Novozymes 
A/S) 
98 - ⁓600 - (Norkvist et al., 
2007) 
CDH from 
Microdochium nivale 
Þ catalase (Catazyme
®
  
25 L from Novozymes 
A/S) 
100 100 300-380 7.9-11.5 (Budtz et a., 
2005 
CDH from 
Termitomyces clypeatus 
⁓100 100 300 0.01 (Saha et al., 
2008) 
CDH from 
Sporotrichum 
thermophile 
- - - - (Canevascini et 
al., 1982) 
CDH from white mold 
Þ laccase from 
Trametes versicolor 
- - - 1.8 (Dhariwal et 
al., 2006) 
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Carbohydrate oxidase 
from Microdochium 
nivale Þ catalase 
(Catazyme
®
  25 L from 
Novozymes A/S) 
>98 100 720 ⁓4.0 (Hua et al., 
2007) 
Carbohydrate acceptor 
oxidoreductase from 
Paraconiothyrium sp. 
100 100 420-900 14.3 (Kiryu et al., 
2008) 
Cellooligosaccharide 
oxidase from 
Sarocladium Oryzae 
F137 Þ catalase 
90 100 720 2.1 (Lee et al., 
2006) 
PDH from various 
Agaricus species 
- 83-95 960-
2880 
- (Volc et al., 
2004) 
Hexose oxidase from 
Chondrus crispus 
- - - - (Savary et al., 
2001) 
Glucooligosaccharide 
oxidase from 
Acremonium 
Strictum T1-38 
Þ catalase 
98 100 240 6.7 (Lin et al., 
1993) 
Lactose-oxidizing 
enzyme from 
Paraconiothyrium 
sp. KD-3 þ catalase 
75-100 100 600-
3000 
7.4-11.5 (Murakami et 
al., 2008) 
Lactose dehydrogenase 
from Pseudomonas 
Graveolens ATCC-4683 
Þ lactonase 
100 100 - - (Nishizuka & 
Hayaishi, 
1962) 
Pseudomonas 
graveolens ATCC-4683 
- - - - (Wright & 
Rand, 1973) 
Pseudomonas 
graveolens 14 
100 96 9900 ⁓0.5 (Stodola & 
Lockwood, 
1947) 
Pseudomonas taetrolens 
LMG 2336 
66-100 100 2880-
4800 
0.59-1.12 (Alonso et al., 
2011) 
Pseudomonas taetrolens 
LMG 2336 
6-100 100 3600 0.04-1.3 (Alonso et al., 
2012) 
Pseudomonas sp. 
LS13-1 
>90 100 10800 0.46-1.0 (Miyamoto et 
al., 2000) 
Pseudomonas sp. 
LS13-1 
>90 100 7200 1.5-1.9 (Miyamoto et 
al., 2000) 
Pseudomonas calco- 85-90 - 11520 ⁓0.5 (Kluyver et al., 
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acetica 1951) 
Pseudomonas quercito-
pyrogallica 
⁓90 - ⁓46000 ⁓0.5 (Kluyver et al., 
1951) 
Burkholderia cepacia 
No. 24 
⁓100 100 900-
1620 
5.6-10.01 (Murakami et 
al., 2003; 2006) 
Burkholderia cepacia 
No. 216 
100 100 3000 0.2 (Murakami et 
al., 2002) 
Acetobacter orientalis 
KYG22 
36 - 4320 0.1 (Kiryu et al., 
2009) 
Acetobacter orientalis 
KYG22 
⁓100 - 4320 ⁓0.4 (Kiryu et al, 
2012) 
Paraconiothyrium 
Sp. 
- - - - (Nakano et al., 
2006) 
Halobacterium 
saccharovorum 
97 100 2880 - (Tomlinson et 
al., 1978) 
Paracolon bacteria B1x 
urease-positive and 
C6 urease-negative 
100 100 2880 ⁓0.4 (Eddy, 1958) 
Penicillium 
chrysogenum 
⁓6 - 7200 0.04-0.07 (Cort et al., 
1956) 
Table 1.6. Overview of LBA production by biocatalytic oxidation of lactose (Gutiérrez et al., 
2012). 
 
Although a lots of studied were concerned on the LBA microbial production through 
oxidation of refined lactose, recent interesting were focused on the possibility to employ 
inexpensive feedstock as fermentation broth for Pseudomonas species, like dairy industry by-
product suggests a promising strategy to achieve cost-effective upgrading of these fractions. 
This approach also provides an environmentally-friendly and competitive alternative to costly 
and harmfully upstream processing step for LBA production through chemical or enzymatic 
oxidation of refined lactose (Alonso et al., 2011).      
Improvements in microbial processes for LBA production can be obtained using inexpensive 
feedstock as a lactose source, like dairy industry wastes; several studies have been focused on 
whey use but few ones are with ricotta cheese whey (Alonso et al, 2011). 
 
1.3 INDUSTRIAL IMPLEMENTATION STRATEGIES  
In recent years, bio-based production of platform chemicals blocks, basic starting materials 
for producing chemical intermediates and building compounds,  from renewable resources has 
attracted increasing attention as an alternative to petrochemical production methods, due to 
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the limited nature of fossil oil, increasing oil prices, and global concerns on sustainability and 
the environment. The techniques and strategies for developing microbial strains for chemicals 
production have advanced rapidly (Jang et al., 2012). 
Interesting features of biological systems include flexibility, selectivity of the substrate, 
regioselectivity, chemoselectivity, enantioselectivity and catalysis ambient temperature and 
pressure. However, the challenge is the bioprocess competitiveness from the point of view of 
costs with assets of existing capital chemical processes associated with the production of 
chemical raw materials. The chemical industry serves nearly all sectors of the manufacturing 
industry and is often indicated as a key industry. The range of markets served and volume of 
generated product resulting in worldwide consumption of 270 million tons of oil and gas a 
year. Only in the US chemical industry it converts $ 27 billion of raw materials in 419 billion 
dollars of products each year, with industry revenues globally 1.5 billion dollars, and 
consumes 7% of the annual energy production. The biggest challenge the chemical industry is 
the long-term sustainability: the issue is often addressed by focusing on the use of renewable 
energy reserves rather than fossil fuels. In this regard, it is pushing towards the exploration of 
bioprocesses for the production of chemicals (Green chemistry): recently there has been a 
renewed interest in the use of conversion of biomass for the production of valuable products 
(Thomas et al., 2002). 
 
1.3.1 Cells Immobilization  
Biofilm formation is a natural process where microbial cells attach to a support (inorganic or 
organic material) or form aggregates, without chemicals use, forming a high-density cells 
layers called “biofilm” (Qureshi et al., 2005). 
Immobilization of microorganisms in a polymeric matrix exhibits great potential, especially, 
in a packed bed or fluidized bed reactors, with positive effects in terms of particle size 
control, biomass regeneration and reutilization, easy separation of cells from fermentative 
broth and high cells density (Vijayaraghavan et al., 2007). 
Interesting application in food industry and treatment of food industry wastes were 
investigated concerning the immobilization cells strategy; but the strictly rules on food safety 
led to choose immobilization cells supports with precise characteristics of inalterability and 
absence of reactivity of the material (Kosseva et al., 2009).    
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Table 1.7. Comparison of different types of reactors with biofilm reactors (Qureshi et al., 
2005). 
 
 
Fig. 1.18. Basic methods for biocatalyst immobilization (Kosseva et al., 2009) 
 
1.3.2 Downstream process 
The key factors for the advance of the bio-based production of platform chemicals include the 
development of natural or engineered microorganisms for efﬁcient production, access to cost-
competitive and sustainable resources, and optimization of downstream processes, to compete 
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against the classical petrochemical processes and guarantee industrial implementation  (Jang 
et al., 2012). 
In the last few years new approaches for LBA recovery and purification have been performed 
(Table 1.6); in particular several attempts have been made to separate and purify LBA after 
bioconversion processes and the techniques adopted depends on the nature of the matrix 
employed for LBA production, because metabolites from the fermentative broth could 
represent a drawback for the outcome of purification process in comparison with downstream 
processing for LBA recovery after catalytic production from refined lactose  (Alonso et al., 
2013). 
 
 
Table. 1.8. Overview of downstream processes for LBA purification (Alonso et al., 2013).  
 
The first attempt for LBA purification after microbial fermentation was suggested by 
Lockwood and Stodola (1950), which performed a precipitation step through ethanol addition 
to the culture supernatant after fermentation (Lockwood and Stodola, 1950). Magariello et al. 
(1956), after an electrolytic reaction for lactose oxidation to LBA, proposed a vacuum 
evaporation of LBA solution to a syrup and a dehydration by distillation with dioxane and 
toluene for obtaining a dry residue; this is added with dioxane and toluene again and the 
process repeated. The finally dry residue obtained was further crystallized (Magariello et al., 
1956). Alternatively the proposed processed included treating the crude electrolysis reaction 
solution with cation and anion exchange resins to remove inorganic ions, and spray-drying the 
effluent aqueous solution to convert LBA in a dry mixture of acid and δ-lactone (Magariello 
et al., 1956). Jones and Ho (2002) proposed an optimization of the method for LBA recovery 
thanks to a first evaporation step (45 min at 70°C) followed by a crystallization through a 
precipitation method and a final ion-exchange process. Because calcium lactobionate is 
cheaper compared to the acid form, an object of the patent is to prepare LBA using calcium 
lactiobionate as a starting material. A final freeze-drying process allowed to achieve a LBA 
recovery rate of 79% (Jones and Ho, 2002).       
Also electrodialysis technique  have been used for separate LBA from a solution contained 
lactose, fructose and sorbitol too, resulting from a biotechnological process catalysed by the 
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enzymes GFOR and GL of  Zymomonas mobilis. However, the low yield obtained (38.7%) 
and  the new trends in food industries (Daufin et al., 2001) are focused on the use of green 
processes (Peretti et al., 2009). Cation exchange resins purification can be considered a green 
process and Pedruzzi et al. (2007; 2008) studied different chromatographic systems to 
perform the separation of the quaternary mixture (lactose, fructose, LBA and sorbitol) from 
an enzymatic process carried out through GFOR and GL activity. But the resins need 
sometimes to be changed because of that they can represent an additional cost for the industry 
(Pedruzzi et al., 2008). In the last years, membrane filtration processes were presented as a  
valuable green technique in order to obtain purified extracts (Mirabella et al., 2014). For 
several years membrane processes have been presented with more promising application in 
food industry and the mail application are in dairy industry, beverages and egg products, and 
wine industry, limiting their environmental impact (Daufin et al., 2001)  
Tangential cross-flow filtration is a physics-mechanical separation procedure. While the 
medium flows through the membrane tangentially the filtrate (permeate) is carried away at a 
right angle. This filtering method is also called “dynamic filtration”. The compounds to be 
separated do not undergo any chemical modification which means that they can be recycled or 
recovered. By choosing an appropriate pore size low-molecular substances are able to pass 
through the membrane while macro molecules are being held back.  
Inorganic membranes manufactured by atech innovations gmbh are made of alumina oxide 
(Al2O3). These are composite membranes which are produced by applying a coat to a highly 
porous carrier material. This coat makes up the actual membrane coat.  
The supporting material is made of an extruded mix of silicon carbide which is sinter-fused to 
its defined mean pore by using an exact control of temperature and moisture. The layer is then 
sinter-fused to the supporting material which results in a structure with a very high stability.    
Atech membranes are characterized by high thermal stability, resistance to chemicals, high 
mechanical stability (hammering), high filtrate yield, easily washed and regenerated steps, 
low operating costs due to long service life (Ref: ‘membranes protocol’ by atech innovations 
gmbh).   
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2. AIM OF THE WORK 
 
Cheese Whey (CW) and Ricotta Cheese Whey (RCW), obtained after cheese and ricotta 
cheese manufacture respectively, are the most important dairy industry wastes (80–90% of the 
volume of milk transformed) (Pantazaki et al., 2009); and their significant lactose amount (4-
5% w/w) represent a disposal problem for agro-industrial companies. Currently, about 30% of 
annual world cheese whey production (about 177 million tonnes in 2006) (Alonso et al., 
2011) and  
RCW is a high pollution dairy industry waste. It is characterized by BOD and COD values of 
50 g/L and 80 g-L, respectively, a lactose concentration of about 40-45 g/L, without 
significant concentration of proteins and lipids. It is a by-product obtained after ricotta cheese 
production, which consists of the following steps: acidification of raw cheese whey and 
heating up to 85–90ºC for about 25 min, to promote the precipitation of most of whey proteins 
to get the cottage cheese, known as ricotta cheese. The liquid solution remaining after cheese 
separation is actually the so-called Ricotta Cheese Whey, which, due to both the severe 
thermal treatment and the addition of acid salts, has different characteristics with respect to 
raw cheese whey (Sansonetti et al., 2009). 
Although about 30% of world production of cheese whey remains underutilized, destined to 
become waste or animal feed. The environmental and economic interests that require a greater 
amount of serum is converted into high value-added products (S. Alonso et al., 2011). 
Lactobionic acid (LBA) is an aldonic acid obtained from lactose oxidation, which chemical 
structure comprises a galactose molecule bound to a molecule of gluconic acid via an ether 
linkage (Gutiérrez et al., 2012). This acid presents a lot of recently discovered biological 
activities, and a great therapeutic potential due to its excellent biocompatibility, 
biodegradability and non-toxicity, but also its chelating properties, amphiphilic and 
antioxidants (S. Alonso et al., 2013). LBA has important commercial use as an ingredient in 
solutions used to stabilize the organs prior to transplantation, but is also used as a new 
ingredient in care products skin and in food industry as acidulante with sweet taste and 
functional beverages fortified with essential minerals such as iron and copper. It also has an 
important role as functional supplementation of calcium (Gutiérrez et al., 2012). To date, the 
lactobionic acid is produced in greater part through chemical synthesis in a high-energy-
intensive process, which requires the use of expensive metal catalysts and which may also 
lead to the formation of products from unwanted side reactions. Its biotechnological 
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production has not been developed so intensely until now, in comparison to that of other 
organic acids such as 
lactic, succinic or citric. However, recently, the bio-production of LBA has emerged as a 
promising and flexible approach to satisfy the growing demand for this bio-product. In 
addition, the environment friendly and cost efficient production of bio-LBA may be carried 
out using dairy industry by-products as cheap raw materials: in fact, although they represent a 
natural source of protein and lactose, the increase of their production and their treatment 
remain two of the major problems for the dairy industry. Therefore, the search for innovative 
solutions disposal and management of this flow of high strength waste is become the driving 
force behind the development of new sustainable processes (S. Alonso et al., 2013). 
Thus, the aim pursued with this project is the design and development of an integral process, 
using membrane filtration, to produce a purified extract of LBA from the fermentation broth 
with Ricotta Cheese Whey as substrate, and Pseudomonas and Acetobacter sp. as bacteria 
strains. Improvement of bioconversion performance were performed with different strategies 
(Stirred-Tank and Packed-Bed reactors), in order to achieved an industrial implementation of 
the process. A finally approach of downstream process with high performance tangential flow 
filtration was investigated for a purification of LBA from fermentative broth.  
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3. MATERIALS AND METHODS 
 
3.1 MICRORGANISMS, MEDIA AND SUBSTRATES EMPLOYED 
Seven bacterial strains were used in this study. Pseudomonas taetrolens LMG 2336  obtained 
from the Belgian Coordinated Collection of Microorganisms (Gent, Belgium)- -and six 
(Pseudomonas taetrolens DSM 21104; Pseudomonas fluorescens DSM 50106; Pseudomonas 
chlororaphis DSM 50083; Pseudomonas citronellolis DSM 50382; Acetobacter orientalis 
DSM 15550; Acetobacter syzygii DSM 15548) obtained from DSMZ culture collection. The 
strains were maintained frozen (-80°C) in their corresponding growth media containing 20% 
v/v glycerol.   The Pseudomonas sp. and Acetobacter sp. strains were grown on nutrient broth 
and acetic acid bacterium media, respectively. 
The composition of bacterium media and the optimal conditions of growth (temperature and 
pH) was reported in Table 3.1, as indicated by LMG and DSMZ bacteria collections. 
 
Microrganism Media, 
Temperature 
Composition (g/L) 
• Pseudomonas taetrolens LMG 2336 M2, 28°C KH2PO4     0.45 
Na2HPO4 x 12 H2O     2.39 
Beef extract     1 
Yeast extract     2 
Peptone     5 
NaCl     5 
Agar     15 
pH 6.8 
• Pseudomonas taetrolens DSM 21104 M535, 28°C Trypticase Soy Broth     30 
Agar     15 
pH 7.3 
• Pseudomonas fluorescens DSM 50106 
• Pseudomonas chlororaphis DSM 50083 
• Pseudomonas citronellolis DSM 50382 
M1, 30°C Peptone     5 
Meat extract     3 
Agar     15 
pH 7.0 
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• Acetobacter orintalis DSM 15550 
• Acetobacter syzygii DSM 15548 
M989, 30°C Meat  extract     5 
Yeast extract     5 
Glucose     5 
MgSO4 x 7 H2O     1 
Agar     15 
pH 6.6-7.0 
Table 3.1. Composition of bacterium media and the optimal conditions of growth 
 
Experiments for testing lactose oxidation ability of the bacteria strains were performed with 
different substrates as lactose source as reported in Table 3.2. 
Substrates Composition (g/L) 
S1. Fermentative broth+Synthetic Lactose 
(from Sigma-Aldrich) 
D-Lactose monohydrate 98%     10-50 
Peptone     2 
Yeast extract     1 
K2HPO4     0.2 
S2. Mineral Salt Medium+Sigma Lactose 
(from Sigma-Aldrich) 
D-Lactose monohydrate 98%     50 
Glucose     0.1 
KH2PO4     0.7 
Na2HPO4     0.9 
NaNO3     2  
MgSO4 x 7 H2O     0.4 
CaCl2 x 2 H2O     0.1 
Trace Element Solution     2mL 
NaCl     5 
S3. Ricotta Cheese Whey Ricotta Cheese Whey from bovine milk  
(provided by Granarolo, Bologna, Italy) 
S4. Permeate X  Permeate X (obtained after a RCW ultrafiltration 
process-500 KDa) 
S5. Permeate 4  Permeate 4 (obtained after a permeate X ultrafiltration  
process-30 KDa) 
S6. Fermentative broth+Concentrated 
Lactose (obtained after a RCW 
ultrafiltration and nanofiltration processes)  
Concentrated Lactose     50 
Peptone     2 
Yeast extract     1 
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K2HPO4     0.2 
S7. Mineral Salt Medium+Concentrated 
Lactose (obtained after a RCW 
ultrafiltration and nanofiltration processes) 
Concentrated Lactose     50 
Glucose     0.1 
KH2PO4     0.7 
Na2HPO4     0.9 
NaNO3     2  
MgSO4 x 7 H2O     0.4 
CaCl2 x 2 H2O     0.1 
Trace Element Solution     2mL 
NaCl     5 
Table 3.2. Substrates employed as lactose source  
 
Permeate X and 4, and Concentrated Lactose were obtained after Ultrafiltration and 
Nanofiltration processes, respectively, of RCW for proteins recovery and valorization as 
bioactive compounds (project S.O.F.I.A.), as reported in Fig.3.1.  
 
 
Fig 3.1. Biorefinery process of Ricotta Cheese Whey 
 
Composition and chemical characterization of the RCW employed were presented in Table 
3.3 (data provided by project S.O.F.I.A.’s partners). 
Ricotta 
Cheese 
Whey (0) 
 
 
UF1 (500 KDa) 
 
UF2 (30 KDa) 
 
NF 
 
OI 
    
    
Salts Whey 
Proteins (1) 
Peptides 
(2) 
Concentrated 
Lactose 200 g/L (3) 
Water 
Permeate 
(X) 
Permeate 
(4) 
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0.014
Galactose
(g/100g)
0.0043.950.141.296.321.0293.705.31
Glucose
(g/100g)
Lactose
(g/100g)
Lipids
(g/100g)
Ashes
(g/100g)
Dry
(g/100g)
Density
(g/mL)  
Acidity
(°SH/100mL)
pH
Sugars
0.0961.711.551.270.3790127
Soluble 
Peptides
(g/100g)
BlgA
(mg/100g)
BlgB
(mg/100g)
Ala 
(mg/100g)
Total 
Proteins
(g/100g)
Lactic
(mg/100g)
Citric
(mg/100g)
Whey ProteinsAcids
 
Table 3.3. Biorefinery process of Ricotta Cheese Whey 
 
3.2 INOCULUM PREPARATION  
A loopful of each strain grown on agar plate was used to inoculate a 250 mL flask containing 
100 mL of nutrient broth (DSM or LMG medium as reported in Table 3.1), acetic acid 
bacterium medium (Table 3.1) or synthetic reach medium supplemented with lactose at a final 
concentration of 10 g/L (substrate S1-Table 3.2).  The preculture flasks were incubated on an 
orbital shaker at 150 rpm and 30°C for 12h and 48h for Pseudomonas and Acetobacter strains, 
respectively. Active cells from precultures were then employed as inoculum in shake flasks or 
in bioreactors (STR and PBR) containing synthetic medium with lactose (substrates S1, S2, 
S6, S7-Table 3.2), sterile RCW (substrate S3-Table 3.2) from bovine milk (kindly provided 
by Granarolo, Bologna, Italy), or permeate X and 4 (substrates S4, S5-Table 3.2) adjusted to 
appropriate pH (7 for Pseudomonas species and 6.6 for Acetobacter) by adding NaOH 2M 
before autoclaving. 
 
3.3 BATCH EXPERIMENTS WITH SYNTHETIC LACTOSE (from Sigma-Aldrich) IN SHAKE 
FLASKS  
 
3.3.1 Screening with 10 g/L of synthetic lactose in different conditions 
Bioconversion experiments were performed, for the 7 bacteria strains selected, in 500 mL 
flasks containing 250 mL of fermentative reach broth with 10 g/L of synthetic lactose 
purchased from Sigma-Aldrich (substrate S1-Table 3.2), sterilized by autoclaving at 121°C 
for 20 minutes. The flasks were seed with 2 different inoculum size (5% vol/vol or 10 g/L of 
wet biomass) grown for 12 h at 30°C and 150 rpm on an orbital shaker, on 2 different 
preculture media (bacterium media from Table 3.1 or substrate S1 from Table 3.2), as 
reported in paragraph 3.2.  
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The cultures were incubated on an orbital shaker at 150 rpm and 30°C for up to 144 h. 
Samples were aseptically withdrawn after 0, 3, 6, 24, 48, 72 and 144 h of incubation for 
growth monitoring and quantification of produced LBA and residual lactose. The tests were 
conducted in duplicate as independent experiments. 
 
3.3.2 Batch experiments with 50 g/L of synthetic lactose in different conditions 
After the first screening in fermentative reach broth with 10 g/L of synthetic lactose 
purchased from Sigma-Aldrich (S1-Table 3.2), a bioconversion experiments with highest 
synthetic lactose concentration (50 g/L) were performed with the best producers strains. As 
culture media were employed a synthetic reach medium and a mineral salt medium (MSM), 
both supplemented with 50 g/L of synthetic lactose from Sigma-Aldrich (S1, S2-Table 3.2). 
500 mL flasks containing 250 mL of fermentative broth were seed with 5% vol/vol as 
inoculum grown for 12 h at 30°C and 150 rpm on an orbital shaker, on bacterium media 
(Table 3.1) as preculture media, as reported in paragraph 3.2.  
The cultures were incubated on an orbital shaker at 150 rpm and 30°C for up to 144 h. 
Samples were aseptically withdrawn after 0, 3, 6, 24, 48, 72 and 144 h of incubation for 
growth monitoring and quantification of produced LBA and residual lactose. The tests were 
conducted in duplicate as independent experiments. 
 
3.4 BATCH EXPERIMENTS WITH LACTOSE (from Ricotta Cheese Whey) IN SHAKE 
FLASKS  
3.4.1 Screening with Ricotta Cheese Whey 
A second screening was performed with the 7 selected bacteria strains, in 500 mL flasks 
containing 250 mL with Ricotta Cheese Whey (RCW) (S3-Table 3.2) as substrate. The flasks 
were seed with 5% vol/vol as inoculum grown for 12 h at 30°C and 150 rpm on an orbital 
shaker, on bacterium media (Table 3.1) as preculture media, as reported in paragraph 3.2.  
The cultures were incubated on an orbital shaker at 150 rpm and 30°C for up to 144 h. 
Samples were aseptically withdrawn after 0, 3, 6, 24, 48, 72 and 144 h of incubation for 
growth monitoring and quantification of produced LBA and residual lactose. The tests were 
conducted in duplicate as independent experiments. 
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3.4.2 Batch experiments with permeate X (UF-500 KDa), permeate 4 (UF-30 KDa) and 
concentrated lactose (NF) in different conditions 
Bioconversion experiments for the best producers strains were performed with different RCW 
permeate as substrate: permeate X obtained after RCW ultrafiltration process (500 KDa) (S4-
Table 3.2), permeate 4 obtained after permeate X ultrafiltration process (30 KDa) (S5-Table 
3.2), a synthetic reach medium and a mineral salt medium (MSM), both supplemented with 
concentrated lactose obtained after a RCW ultrafiltration and nanofiltration processes (S6 and 
S7-Table 3.2), according with Fig. 3.1. 500 mL flasks containing 250 mL of fermentative 
broth were seed with 5% vol/vol as inoculum grown for 12 h at 30°C and 150 rpm on an 
orbital shaker, on LMG and DSM bacterium media (Table 3.1) as preculture media, as 
reported in paragraph 3.2.  
The cultures were incubated on an orbital shaker at 150 rpm and 30°C for up to 144 h. 
Samples were aseptically withdrawn after 0, 3, 6, 24, 48, 72 and 144 h of incubation for 
growth monitoring and quantification of produced LBA and residual lactose. The tests were 
conducted in duplicate as independent experiments. 
 
3.4 SCALE UP IN PACKED-BED REACTORS (PBR) 
3.4.1 Preliminary tests for cells immobilization 
Batch experiments in 500 mL shake flasks containing 250 mL of working volume (100 mL of 
packing volume and 150 mL of fermentative medium) were performed with the selected 
strains with 3 different inorganic supports: ceramic material (Vukopor), sintered glass 
(Biopearl) and polypropylene (Sagm500) (Fig. 3.2).  
  
1. VUKOPOR (Lanik, Boskovice, CZ): 
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              2. BIOPEARL (Haquoss):  
 
                       
                           sintered glass                                                                                                                                       
                           molecular structure porous and adsorbent  
                           diameter about 5mm 
                           colour: white                                                      
 
 
3. SAGM 500 (Refill - Tech Solutions Srl. Biassono, MB): 
 
 
            polypropylen virgen  
            suspended attached growth media: 500 m2/m3 
            specific weight: 0.95 Kg/dm3 
                  colour: white                                                          
                                                                                             
 
Fig 3.2. Supports employed in the preliminary shake flasks experiments for cells 
immobilization 
 
In a first batch with RCW (S3-Table.3.2) as substrate (Batch 1), 3 shake flasks with supports 
and 1 of positive control (without supports) were seed with 10% vol/vol as inoculum grown 
for 6-8 h at 30°C and 150 rpm on an orbital shaker, on 500 mL shake flasks containing 250 
mL of RCW (S3-Table.3.2) as starter culture. The starter culture was seed with 5% vol/vol as 
inoculum grown for 12 h at 30°C and 150 rpm on an orbital shaker, on LMG and DSM 
bacterium media (Table 3.1) as preculture media, as reported in paragraph 3.2.  
The cultures were incubated on an orbital shaker at 80 rpm and 30°C for up to 10 days. 
Samples were aseptically withdrawn after 0, 24, 48, and 240 h of incubation for biofilm 
formation monitoring and quantification of produced LBA and residual lactose.  
A second batch with synthetic reach medium supplemented with concentrated lactose 
obtained after a RCW ultrafiltration and nanofiltration processes (S6-Table 3.2) as substrate 
(Batch 2), was performed using supports with biofilm from Batch 1 as inoculum.  
Cultures incubation and sampling were carried out after 0, 24, 48 and 96 h as reported 
previously. The tests were conducted in duplicate as independent experiments. 
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3.4.2 PBR 
Scale up in 1L-Packed Bed Reactors (PBRs) were set up  for the selected strains employing  
Vukopor (ceramic material) and Biopearl (sintered glass) as inorganic supports, at 30°C, pH 7 
and 40 mL/min of recycle rate.  
 
 
Fig 3.3. PBRs data 
 
In a first batch (Batch 1) PBRs with RCW (S3-Table.3.2) were seed with 25% vol/vol as 
inoculum grown for 6-8 h at 30°C and 150 rpm on an orbital shaker, on 500 mL shake flasks 
containing 250 mL of RCW (S3-Table.3.2) as starter culture. The starter culture was seed 
with 5% vol/vol as inoculum grown for 12 h at 30°C and 150 rpm on an orbital shaker, on 
LMG and DSM bacterium media (Table 3.1) as preculture media, as reported in paragraph 
3.2. Samples were aseptically withdrawn after 0, 24, 48, 96, 120, 144, 168, 192, 240 h of 
incubation for biofilm formation monitoring and quantification of produced LBA and residual 
lactose. The tests were conducted in duplicate as independent experiments. 
A second batch with synthetic reach medium supplemented with concentrated lactose 
obtained after a RCW ultrafiltration and nanofiltration processes (S6-Table 3.2) as substrate 
(Batch 2), was performed using supports with biofilm from Batch 1 as inoculum.  
Cultures incubation and sampling were carried each 24 h from initial time up to 17 days of 
incubation. The tests were conducted in duplicate as independent experiments. 
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Fig 3.4. Layout of Packed Bed Reactor (PBR) 
 
3.5 SCALE UP IN STIRRED-TANK REACTORS (STR) 
3.5.1 Batch fermentations in 3L-STR  
LBA production by the most promising strains was performed in a 3liter bioreactor 
(BIOSTAT® B Sartorius) with a working volume of 1.5 L at 30°C, thanks to thermostatically 
controlled water in reactor jacket, and pH 6.8-7, thanks to a computer-controlled peristaltic 
pumps via automatic addition of 8M NaOH and 2M H2SO4. Dissolved oxygen tension was 
maintained above 20% through a cascade control between agitation rate (200-800 rpm) and 
aeration rate (0.12-0.3 Lpm). Excessive foam formation was limited by automatic addition of 
1:10-diluited Y-30 emulsion (Sigma-Aldrich). Fermentative broth (RCW ‘S3’, permeate 4 
‘S5’ and synthetic reach medium supplemented with concentrated lactose from RCW UF and 
NF ‘S6’-Table 3.2), were seed with 5% vol/vol as inoculum grown for 12 h at 30°C and 150 
rpm on an orbital shaker, on LMG and DSM bacterium media from Table 3.1 as preculture 
media, as reported in paragraph 3.2. 
Samples were aseptically withdrawn after 0, 3, 6, 8, 24, 30, 48, 54, 72 and 80 h of incubation 
for growth monitoring and quantification of produced LBA and residual lactose. This test was 
conducted in duplicate as independent experiments. 
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3.5.2 Fed-Batch fermentations in 3L-STR 
A fed-batch experiments were performed in 3L-STR with permeate 4 as substrate (Table 3.2-
S5), supplemented with 250 mL of Concentrated Lactose (obtained after a RCW 
ultrafiltration and nanofiltration processes) after 80 h of incubations. Inoculum and withdraws 
are similar to those reported previously (par. 3.5.1).  
 
3.5.3 Batch fermentations in 15L-STR 
Batch experiments were performed in a 15-L Stirred-Tank Reactor (BIOSTAT ® CTplus & 
Cplus from Sartorius) employing Pseudomonas taetrolens LMG 2336 bacteria strain, with two 
different working volumes (5L and 7L of sterilized RCW). The system is equipped with the 
measurement and control systems for steam heating (including automatic in-situ sterilization), 
agitation, pH-value, pO2-value, gassing of the culture vessel, foam control, high foam alarm, 
and level control. The connection to computer systems is possible about the built-in serial RS 
422 interface. The output measured signals to a printer can be made by the built-in serial RS 
232 interface.  
Oxygen partial pressure (pO2) was maintained at 20% through an agitation cascade (from 200 
to 800 rpm) and an aeration cascade (from 0.12 to 0.3 Lpm). pH was maintained up to 7 
thanks to a computer-controlled peristaltic pumps via automatic addition of 8M NaOH and 
2M H2SO4. Temperature was constantly maintained at 30°C by means of the presence of a 
thermostatically controlled water in the reactor jacket. Excessive foam formation was limited 
by automatic addition of 1:10-diluited Y-30 emulsion (Sigma-Aldrich).   Inoculum levels of 
10% (v/v), corresponding at 10 g/L of wet biomass, were employed from overnight 
precultures growth in 4 500 mL-shake flasks contained 250 ml of reach medium each one (for 
a total of 1 L), in an orbital shaker at 30°C and 150 rpm. Samples were aseptically withdrawn 
after 0, 24 and 48 h of incubation for quantification of produced LBA and residual lactose. 
15L-STR Bioreactor cultivations with ricotta cheese whey medium RCW was conducted in 
duplicate as independent experiments. 
 
3.6 DOWNSTREAM PROCESS FOR LBA RECOVERY  
3.6.1 High-Performance Tangential Flow Filtration  
Coltural broth, after fermentation process for lactose oxidation to LBA, has been pretreated 
for removing residual cell by centrifugation step (8000 rpm, 10 min, 4˚C).   
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The bench-scale cross flow unit (from PS Prozesstechnik GmbH) is designed for testing 
membranes and membrane filtration applications in the laboratory. Two membrane housing 
are installed: 
- Housing for 1,8” spiral wound membranes (min. working volume =1000 ml); 
- Housing for 200 cm2  flat sheet membranes (min. working volume=250 ml). 
The tested solution is contained in a double walled tank, and is pumped either through the one 
or the other membrane module with a diaphragm pump (pump controlled with a frequency 
converter; flow range: 1,8-12 L/min (=15-100% on the regulation knob); pressure range: max 
40 bar; as it is a volumetric pump, the flow rate Q [L/min] is proportional to the knob position 
KP [%]: Q=0.12xKP). The pressure is adjusted with a spring loaded pressure regulating valve. 
The operating temperature is regulated automatically, via a PID temperature controller and a 
magnetic valve in the heating/cooling medium line. The unit works batchwise. The operating 
limits are 0-40 bar and 0-60˚C. The main process parameters (pressure, temperature) are 
measured and displayed. All the components are fixed on a stainless steel base plate, and the 
unit has a stainless steel control cabinet with the electronics, power supply of pump and 
instruments. The system is protected against overpressure and overtemperature. The unit is 
compatible with aqueous systems and alcohols. All medium wetted metallic parts are made of 
stainless steel 316L or equivalent (1.4435; 1.4404). All parts and pipes are fixed on a stable 
stainless steel frame (304-1.4301). 
There are three ways to operate the unit: 
- OPERATION MODE “RECYCLING”: the permeate hose goes back to the feed vessel , that 
means the product concentrations remain constant over time. In this way, one determines the 
influence off different operating parameters on permeate flux and retention at a given constant 
concentration. After the start up, the unit is in the recycling mode. 
- OPERATION MODE “CONCENTRATION”: the permeate is collected in a separate vessel. 
The level in the feed vessel decreases and the concentration of the retained soluble 
components increases. Starting from the recycling mode, the end of the permeate hose is put 
into an external vessel (on a scale and tare) for collecting permeate and when the desired mass 
of permeate has been removed, the concentration is stopped by putting the permeate hose 
back to the feed vessel (recycling mode). 
- OPERATION MODE “DIAFILTRATION”: the permeate leaves the membrane module 
(collected in a separate vessel) and is replaced manually with pure water (or solvent) so that 
the level in the feed vessel remains constant. This procedure is used to wash out components 
with low retention (small molecular weight). The diafiltration is stopped when the desired 
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quantity of water has been added, by putting the permeate hose back to the vessel (recycling 
mode). 
Table 3.3 shows the characteristics of the tubular ceramic membrane employed (atech Al2O3-
membrane; single-duct design, type 10/6) 
 
Table 3.4. Characteristics of HPTFF membrane 
 
Three tests have been performed at 30°C and 14-15 bar at different pH values: pH 3 (test 1), 
pH 9 (test 2) and pH 5.44 (test3) with 1L of raw material initial volume. For each test a cycle 
of filtration and a cycle of diafiltration have been performed; bringing to a final volume of 
filtrate (500 mL), diafiltrate (500 mL) and concentrate (500 mL) and monitoring the volume 
of permeate with time and the concentration in the feed, retentate and accumulated permeate 
of LBA and lactose. 
 
3.7 ANALYTICAL METHODS  
1. Bacterial growth was monitored by cell counts using the drop plate method (Herigstad et 
al., 2001) and by the optical density measurement after growth in synthetic medium or RCW, 
respectively. 
2. Specific growth rate (μ) was estimated from CFU/ml values using the following equation:   
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where CFU/mlt and CFU/mlt-1 are the CFU/ml values at two time intervals, OD600t and 
OD600t-1 are the OD600 values at two time intervals and Δt is the time interval between the 
two measurements. 
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3. The pH was measured using a pH meter (Thermo Orion Model 720A, Research Inc., 
Beverly, MA, USA) and a pH probe (Orion 81-04). 
4. Quantification of the produced lactobionic acid and residual lactose was performed by high 
performance liquid chromatography (HPLC). The samples were previously centrifuged to 
remove cell debris (14.000 rpm for 10 min) and filtered through a cellulose acetate membrane 
0,22µm-25 mm filter (GVS Filter Technology). HPLC analyses were carried out in a liquid 
chromatography system (Agilent  1260 Infinity) equipped with an Agilent Hi-Plex Ligand 
Exchange Columns (H+) 300 x 7,8 mm set at 75°C, coupled to a refractive index detector at 
40°C. The mobile phase consisted of a 0.1 mM H2SO4 (pH 3.4) solution at a flow rate of 0.5 
mL/min. Samples were quantified according to HPLC-grade external analytical standards, 
lactose and lactobionic acid, obtained from Sigma-Aldrich (Milan, Italy). Data acquisition and 
analysis were performed with ChemStation software (Agilent). 
5. The operating parameters for High-Performance Tangential Flow Filtration must be chosen 
according to the medium to be filtered. 
c=V/A [m/s]   where:  
c=Velocity inside membrane ducts (approx. 4-6 m/s); V=Feed volume flow; A=Surface of 
ducts flown past. 
Δp= [(P1+P2)/2] – Pp [bar]   where: 
Δp=Trans-membrane pressure (approx. 1.5-3 bar); P1=Pressure at entry of module; 
P2=Pressure at exit of module; Pp=Pressure of permeate. 
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4. RESULTS AND DISCUSSIONS 
 
4.1 BATCH EXPERIMENTS WITH SYNTHETIC LACTOSE (from Sigma-Aldrich) IN SHAKE 
FLASKS 
 
4.1.1 Screening with 10 g/L of synthetic lactose in different conditions 
In the first step, the ability of the seven strains tested in this study to grow and perform the 
oxidation of the lactose to LBA was evaluated on synthetic medium containing 10 g/L of 
chemically pure lactose purchased from Sigma-Aldrich. Four conditions were tested: C1 
(DSMZ or LMG medium as preculture medium and 5% vol/vol of inoculum), C2 (DSMZ or 
LMG medium as preculture medium and 10 g/L of wet biomass as inoculum), C3 (synthetic 
reach medium containing 10 g/L of lactose purchased from Sigma-Aldrich as preculture 
medium and 5% vol/vol of inoculum), C4 (synthetic reach medium containing 10 g/L of 
lactose purchased from Sigma-Aldrich as preculture medium and 10 g/L of wet biomass as 
inoculum). The microbial growth, evaluated by drop-counting and optical density at 600 nm, 
revealed that all Pseudomonas’ strains were able to grow in synthetic medium (Fig. 4.1a, 
4.1b, 4.1c, 4.1d, 4.1e). In particular maximum OD600 values of  1.6±0.1-1.8±0.1 were 
reached  after 72-144 h, corresponding to a maximum cell density of up to 10
9 
CFU/mL 
starting from a cell concentration of  10
7
 CFU/ml , and no significant differences were 
revealed between the 4 conditions.  
 
a)   b)  
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c)   d)  
e)   f)  
                          g)  
Fig. 4.1. Growth values (OD600 nm) of P. taetrolens LMG (a), P. taetrolens DSM 
(b), P. fluorescens DSM (c), P. choloraphis DSM (d), P. citronellolis DSM (e), A. 
orientalis DSM (f), A. sygyzii DSM (g) in synthetic reach medium with 10 g/L of 
chemically pure lactose (Sigma) as substrate, in 4 different conditions of preculture 
media and inoculum (C1, C2, C3, C4). 
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Fig. 4.2. Growth rate (µmax) [h-1] of the seven bacterial strains after 3-6 hours of 
incubation shake flasks with synthetic reach medium with 10 g/L of chemically pure 
lactose (Sigma) as substrate, in 4 different conditions of preculture media and 
inoculum (C1, C2, C3, C4). 
 
The maximum specific growth rate (µmax) was reached after 3-6 hour of incubation (Fig. 
4.2), with the highest of 0.69±0.01/h exhibited by P. chlororaphis DSM. A slower growth 
was observed for A. orientalis which showed a max of  0.03±0.01/h reached between 6h and 
24h of incubation.  
The pH-measurements revealed a significant rise of the broth pH upon growth of P. 
citronellolis and the two Acetobacter reaching values of up to 8.8±0.1-9.26±0.1, starting from 
7±0.1 and 6.8±0.1 respectively; while for P. chlororaphis was observed an increase in the 
case of condition C1 (DSMZ medium as preculture medium and 5% vol/vol of inoculum),  
from 6.8±0.1 to 8.8±0.1. (Fig. 4.3). 
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Fig. 4.3. pH measurement of the seven bacterial strains after 72-144 hours of 
incubation in shake flasks with synthetic reach medium with 10 g/L of chemically 
pure lactose (Sigma) as substrate, in 4 different conditions of preculture media and 
inoculum (C1, C2, C3, C4). 
 
The appearance of nitrogen by-products from metabolized proteins during bacterial growth 
could be the reason of the increase of the pH. The rise of the broth pH was observed also with 
P. taetrolens LMG 2336 by Alonso et al. (2011) employing 0.64 g/L of biomass (about 30% 
v/v) as inoculum into protein-rich sweet cheese medium in shake flasks (Alonso et al., 2011). 
However, under the experimental conditions applied here, in the case of P. taetrolens strains 
we did not observe a significant rise of the broth pH which remained almost constant during 
the growth (around 7). The broth acidification was observed after 24 h of incubation reaching 
the lowest values of pH 4.07±0.23 and pH 4.15±0.01 for the strain P. taetrolens LMG 2336 
and P. taetrolens DSM 21104, respectively, after 48-72 h of incubation. 
The HPLC-measurement performed on cell-free culture supernatants revealed important 
difference between the tested conditions and the selected strains, confirming the pH decrease. 
It showed how the two Pseudomonas taetrolens strains, when DSM or LMG medium as 
preculture medium and 5% vol/vol of inoculum were used (condition C1),  were able to 
produce 6.73±1.9 (conversion yield=76±6%) and 7.69±0.04 g/L (conversion yield=90±1%) of 
LBA by strains LMG 2336 and DSM 21104, respectively, after 72h and 48h of incubations 
(Fig.4.4). These values remained constant after 144h of incubation. 
 
              
Fig. 4.4. Maximum LBA product [g/L] of the seven bacterial strains after 48-72 hours 
of incubation in shake flasks with synthetic reach medium with 10 g/L of chemically 
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pure lactose (Sigma) as substrate, in 4 different conditions of preculture media and 
inoculum (C1, C2, C3, C4). 
 
Although the other Pseudomonas and Acetobacter species were able to grow, no lactose 
consumption and LBA production were detected under the experimental conditions applied 
here.  
P. fluorescens presented a particular behaviour when synthetic reach medium containing 10 
g/L of lactose purchased from Sigma-Aldrich was used as preculture medium (conditions C3 
and C4), because the pH decreased up to 4.8±0.1 and 4.3±0.1, respectively,  but no LBA 
production was detected, probably due to the formation of others acids compounds. 
The obtained results confirm the ability of bacteria from the species P. taetrolens to produce 
lactobionic acid from lactose and are in agreement with those previously reported for P. 
taetrolens where a conversion yield of 0.75 in shake-flask culture was observed after 165 h 
(Stodola and Lookwood, 1947).   
This preliminary screening led to the identified of the best conditions in the use of DSM or 
LMG medium as preculture medium and 5 % vol/vol as inoculum (condition C1), probably 
due to a reduction of cellular stress in the process of biomass recovery and limitation of 
competitive phenomena. 
 
4.1.2 Batch experiments with 50 g/L of synthetic lactose in different conditions 
Based on these results, the two P. taetrolens strains were tested for growth and LBA 
production in the presence of 50 g/L of pure lactose in order to mimic the concentration in the 
RCW.  
With synthetic reach medium, for both strains, the higher lactose amount had not a consistent 
influence on maximum specific growth rate µmax (evaluated by OD600) that is less than the 
values of previously experiments (with 10 g/L Sigma lactose). Indeed the maximum specific 
growth rate, achieved after 3 hours of incubations, of 0.36±0.21 h
-1
 and 0.40±0.07 h
-1
 for P. 
taetrolens LMG 2336 and P. taetrolens DSM 21104, respectively, are similar to the results 
obtained with little amount of lactose (0.38±0.07 h
-1
 and 0.48±0.01 h
-1
 for P. taetrolens LMG 
2336 and P. taetrolens DSM 21104, respectively). Similar considerations can be made for pH 
values since it has been revealed a significant reduction of pH from 7±0.15 up to 3.44±0.08 
and 3.2±0.06 was observed in the case of P. taetrolens LMG 2336 and of P. taetrolens DSM 
21104, respectively (Fig. 4.5a and 4.5b). The drop of the pH value led to a decrease of cells 
vitality, as can be seen with the cells density; the maximum values were reached after 24 
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hours (10
7
 CFU/mL from initial 10
6 
CFU/mL and 10
8
 CFU/mL from initial 10
7 
CFU/mL for 
P.taetrolens LMG 2336 and P.taetrolens DSM 21104, respectively). Afterwards, it 
progressively fall down and no growth, on agar plates for drop counting, were observed until 
up to 144 h of incubation. 
 
a)   b)  
Fig. 4.5. pH values for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) 
in shake flasks with synthetic reach medium with 10 and 50 g/L of chemically pure 
lactose (Sigma) as substrate, inoculated with 5%vol/vol from bacterium medium 
preculture (condition C1). 
 
But the results showed an inhibitory effect of high lactose quantity on oxidized ability of P. 
taetrolens strains; after 48 hours of incubations only 13.16±1.25 g/L (conversion 
yield=80±31%) and 18.61±0.01 g/L (conversion yield=67±3%) of LBA have been detected 
for P. taetrolens LMG 2336 and P. taetrolens DSM 21104, respectively. An increase of 
incubation time did not led to an improve of the yield and a large quantity of lactose remains 
unused from initial 55 g/L; in particular 40.56±4.95 and 32.86±1.18 g/L of lactose for P. 
taetrolens LMG 2336 and P. taetrolens DSM 21104, respectively, after 144 hours of 
incubations (Fig. 4.6a and 4.6b).  
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a)   b)  
    Fig. 4.6. LBA product and residual lactose [g/L] for P. taetrolens LMG 2336 (a) and P.  
    taetrolens DSM 21104 (b) in shake flasks with synthetic reach medium with 50 g/L of  
    chemically pure lactose (Sigma) as substrate, inoculated with 5%vol/vol from bacterium     
    medium preculture (condition C1). 
 
This effect may be due to  the pH drop that resulted in the decrease  of the cell viability and 
the inhibition of the enzymes (lactose oxidase and lactonase) involved in the process of LBA 
production from lactose. Alonso et al. (2012) reported indeed, that in shake-flask 
fermentation, a progressive loss of cellular metabolic activity, membrane polarization and 
integrity was observed during the lactobionic acid production phase (stationary phase). This 
phase involved a morphological changes in Gram negative bacteria (Navarro et al., 2010) that 
combined with higher stressing level conditions led to a drop in bioconversion performance 
(David et al., 2011). 
When mineral salt medium (MSM) added with 50 g/L of synthetic lactose (Sigma) was 
employed, the selected strains showed a sharp fall of the growth and production capabilities, 
although the pH values were very low. In particular for P. taetrolens LMG 2336 after 144 
hour of incubations at 30°C and 150 rpm, 2.03±0.1 g/L of LBA were produced (conversion 
yield=23±1.6%), corresponding to 3.24±0.1 of pH and 0.19±0.01 of OD600 (Fig. 4.7a). 
Instead P. taetrolens DSM 21104, in the same conditions, presented a higher value of OD600 
(0.67±0.04) and similar value of pH (3.27±0.14), without significant LBA production 
(0.71±0.03 g/L with 31±2.4 of conversion yield) (Fig. 4.7b). The pH decrease without LBA 
suggested that probably others acid compounds were produced, like gluconic acid, as reported 
by Alonso et al., 2015, when P. taetrolens LMG 2336, in a substrate with both lactose and 
glucose, produced both LBA and gluconic acid (Alonso et al., 2015). 
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a)   b)  
a)   b)  
    Fig. 4.7. OD600, specific growth rate (µ) [h
-1
], LOG CFU/mL, pH values and LBA product  
    [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) in shake flasks with  
    mineral salt medium and 50 g/L of chemically pure lactose (Sigma) as substrate, inoculated  
    with 5%vol/vol from bacterium medium preculture (condition C1). 
 
4.2 BATCH EXPERIMENTS WITH LACTOSE (from Ricotta Cheese Whey) IN SHAKE 
FLASKS 
The first screening led to the identification of the best preculture and inoculum conditions 
(bacterium medium preculture and 5%vol/vol of inoculum), and the selection of the most 
promising bacteria strains for LBA production via lactose oxidation (chemically pure lactose 
from Sigma-Aldrich).  After this, different experiments were performed in shake flasks 
employed lactose from dairy industry wastes as substrates for LBA production, in order to 
investigate the effects of a natural matrix, compared to a synthetic one, on cells vitality and 
bioconversion performances.  
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4.2.1 Screening with Ricotta Cheese Whey 
Although the first screening in fermentative broth added with chemically pure lactose (Sigma) 
showed how only P. taetrolens strains (LMG 2336 and DSM 21104) were able to produce 
LBA, a second screening with the 7 bacteria strains were performed in shake flasks with 
RCW, having a lactose content of about 40-45 g/L, to confirm or disprove the pervious 
results. 
With the exception of the two P. taetrolens strains, the other three Pseudomonas strains 
(Fluorescens DSM, Choloraphis DSM and Citronellollolis DSM) and Acetobacter sygyzii 
DSM presented higher values of growth rate (µmax) after 3 hours of incubations  when 
fermentative broth with 10 g/L of chemically pure lactose (Sigma) was employed as substrate, 
probably as a consequence of substrate inhibition phenomena  when RCW with higher lactose 
concentration was employed. Instead a slow improvement in specific growth rate value was 
observed for Acetobacter orientalis DSM after 6 hours of incubation with RCW as substrate: 
0.17±0.12 h
-1
 in comparison to 0.10±0.02 h
-1
 with 10 g/L of chemically pure lactose (Sigma) 
(Fig. 4.8a and 4.8b).
 
 
However a similar increase in cell density was observed for the same five strains, in both two 
screening: from 10
7
 to 10
8
 CFU/ml and from 10
6
 to 10
7
 CFU/ml for the three Pseudomonas 
and the two Acetobacter stains, respectively, in the first screening (Sigma Lactose); and from 
10
8
 to 10
9
 CFU/ml for all five strains with the second screening (RCW), probably thanks to a 
positive effect, on cells membrane integrity, of microelements present in a natural matrix.     
 
a)   b)  
    Fig. 4.8. Comparison of specific growth rate values (µ) [h
-1
] between first screening with  
    synthetic reach medium with chemically pure lactose (Sigma) as substrate (a) and second  
    screening with RCW as substrate (b), in shake flasks, inoculated with 5%vol/vol from 
    bacterium medium preculture (condition C1). 
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Instead a slight increase on growth (µmax) of P. taetrolens species was detected after 3 hours 
of incubation at 30°C and 150 rpm in shake flask with RCW: 0.46±0.11 h
-1
 and 0.48±0.16 h
-1
 
for P. taetrolens LMG 2336 and P. taetrolens DSM 21104, respectively, in comparison 
0.37±0.21 h
-1
 and 0.41±0.07 h
-1
 in fermentation broth added with 50 g/L of chemically pure 
lactose (Sigma).   
Both Pseudomonas taetrolens strains reached stationary growth phase based on cell counts 
(1.75x10
9
 and 1.15x10
9 
CFU/mL from 1.9x10
7
 and 1.99x10
7
 initial CFU/mL for 
Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively). 
The cell density remains constant up to 48h of incubation at 30°C and 150 rpm, after which a 
drop in the cell counts from 10
9
 to 10
6
 CFU/mL was observed. The pH of the culture medium 
remains almost constant during the first 24 h of incubation for both strains. Afterwards, it 
progressively drops from 6.42±0.01 to 3.87±0.35 and from 6.4±0.01 to 4.51±0.55 for 
Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively, 
after 72 h of incubation (Fig. 4.9a and 4.9b). Evaluation of LBA production revealed the 
detection of low concentrations of  LBA after 24h of incubation that increases with increasing 
the incubation time to reach 28.7±2.8 g/L and  27.87±1.12 g/L for Pseudomonas taetrolens 
LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively, after 72h of incubation 
(Fig. 4.9a e 4.9b).  
 
a)   b)  
    Fig. 4.9. pH values and LBA product and residual lactose [g/L] for P.taetrolens LMG 2336  
    (a) and P.taetrolens DSM 21104 (b) in shake flasks with RCW as substrate, inoculated with   
    5%vol/vol from bacterium medium preculture (condition C1). 
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In terms of yield (defined as the percentage of lactose converted into lactobionic acid), the 
highest values of 87.8±2.75% and 77.5±1.56% were obtained after 72 h of incubation for 
Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively. 
Further prolongation of the incubation time to 144h did not result in significant improvement 
of the productivity but in a decrease of the yield up to 84±2.75% and 72±2.22% for 
Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively.   
It is interesting to highlight that, using a similar concentration of chemically pure lactose 
(Sigma 61345 D-Lactose monohydrate), lower titres of LBA were achieved by both strains. 
Indeed, as it can be appreciated from figure Fig. 4.6a and 4.6b (50 g/l of chemically pure 
lactose from sigma with Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens 
DSMZ 21104 ); from an initial concentration of 55 g/l of lactose, maximal fermentation 
yields of 14 and 20 g/l of LBA were obtained from Pseudomonas taetrolens LMG 2336 and 
Pseudomonas taetrolens DSM 21104, respectively with a residual lactose concentration of 40 
and 32 g/L. This could be due to the presence in RCW of enzymatic cofactors or compounds 
that enhance the bioconversion rate and/or protect the bacterial cells from the effects of low 
pH,  as can be seen from the improve in cell density (CFU/mL), in particular at low pH 
values. With 50 g/L of Sigma Lactose both P. taetrolens LMG 2336 and DSM 21104 were 
showed no cellular growth after 48 hours, when the pH value was less than 3.5; but with 
RCW medium the buffer effect due to the presence of particular components  led to a gradual 
pH decrease restricting cellular stress conditions (Alonso et al. 2013). 
 
4.2.2 Batch experiments with permeate X (UF-500 KDa) and permeate 4 (UF-30 KDa) 
The second screening with RCW confirmed how P. taetrolens strains were the most 
promising LBA producers employing lactose from a dairy industry waste. 
The lowly amount of whey proteins and peptides presented in the RCW (Table 3.3) suggested 
the possibility of developing an integrated biorefinery process (Fig. 3.1), based on 
ultrafiltration processes, for the enhancement of these bioactive molecules. Therefore, 
bioconversion experiments using the permeated fractions were carried out in shake flasks to 
evaluate the ability of the selected strains to produce LBA: permeate X, obtained from the 
UF-500KDa of RCW for the removal of serum proteins, and permeate  4, obtained from the 
UF permeate of 30KDa-X for the peptides removal.   
With permeate X, both P. taetrolens LMG 2336 and DSM 21104 achieved 4.72 x10
9
 and 
6.03x10
9
 CFU/mL after 48 h of incubation at 30°C and 150 rpm, but P. taetrolens DSM 
21104 was presented higher maximum specific growth rate (µmax) of 0.48±0.04 h
-1
 in 
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comparison of 0.17±0.02 h
-1
 for P. taetrolens LMG 2336 after 3 h. The longer exponential 
growth phase of P. taetrolens DSM 21104, also reported by a constant value of pH up to 48 h 
compared to 24 h for P. taetrolens LMG 2336, had a mild negative effect on bioconversion 
yield: 29.22±4.04 g/L (83±0.6% conversion yield) and 32.43±0.35 g/L (87±3% conversion 
yield) after 144h of incubation for DSM 21104 and LMG 2336 strains respectively (Fig. 4.10a 
e 4.10b).  
 
a)   b)  
 
a)   b)      
    Fig. 4.10. Specific growth rate (µ) [h
-1
], LOG CFU/mL, pH values, LBA product and  
    residual lactose [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) in  
    shake flasks with permeate X (UF-500KDa) as substrate, inoculated with  5%vol/vol from  
    bacterium medium preculture (condition C1). 
 
Similar behaviur was detected for P. taetrolens DSM 21104 also with permeate 4 as substrate: 
4.79x10
9
 CFU/mL after 48 h of incubation at 30°C and 150 rpm, starting from 1.13x10
8
 
CFU/mL; maximum specific growth rate (µmax) of 0.4±0.04 h
-1
, in comparison of 0.16±0.01 
h
-1
 for P. taetrolens LMG 2336 after 3 h, and 27.4±4.04 g/L  of LBA product after 144 h of 
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incubation with 0.86±0.08 of conversion yield. While the growth of P. taetrolens LMG 2336 
was similar between the employment of permeate X and permeate 4 as substrates, the LBA 
production presented significant improvements in the second case: 36.57±4.17 g/L  (89±11% 
of conversion yield) after 144 h of incubation (Fig. 4.11a and 4.11b). This is probably due to a 
macromolecules removal with an ultrafiltration at 30KDa step, that affected enzymes 
involved in lactose oxidations (paragraph 1.2.3; page 24). 
 
a)   b)  
a)   b)  
    Fig. 4.11. Specific growth rate (µ) [h
-1
], LOG CFU/mL, pH values, LBA product and  
    residual lactose [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) in  
    shake flasks with permeate 4 (UF-30KDa) as substrate, inoculated with  5%vol/vol from  
    bacterium medium  preculture (condition C1). 
 
4.2.3 Batch experiments with 50 g/L of concentrated lactose (NF) in different conditions 
A final nanofiltration step of the biorefinery process (Fig. 3.1) was performed on permeate 4 
for achieving a concentrated lactose (250 g/L). In order to evaluate difference between 
chemically pure lactose and bio-based lactose bioconversion experiments were carried out, in 
different conditions: synthetic reach medium and mineral salt medium (MSM) employing 
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concentrated lactose as substrate for LBA production up to a final concentration of 50 g/L, in 
order to mimic the lactose concentration in RCW, permeate X, and permeate 4 (paragraph 
4.2.1 and paragraph 4.2.2). 
When synthetic reach medium supplemented with 50 g/L of concentrated lactose was used, 
maximum cell density of 2.15x10
9
 CFU/mL after 48 h of incubation at 30°C and 150 rpm, 
was achieved for P. taetrolens LMG 2336, starting from 1.39x10
8
 CFU/mL. Instead for P. 
taetrolens DSM 21104 the maximum cell density was reached just after 24 h: in particular 
4.35x10
9
 CFU/mL, starting from 6.84x10
7
 CFU/mL. Different growth performance for both 
P. taetrolens strains, in comparison with shake flasks experiment with RCW, permeate X and 
permeate 4, was showed with the  maximum specific growth rate (µmax) values: 0.27±0.04  
h
-1
 and 0.19±0.02 h
-1 
for Pseudomonas taetrolens LMG 2336 and Pseudomonas taetrolens 
DSM 21104 respectively, as also reported in Table 4.1. LBA detection presented high value 
for P. taetrolens LMG 2336, in particular 40.14±0.86 g/L with 91±6% of conversion yield, 
after 72h of incubation at 30°C and 150 rpm, consuming all the lactose initially presents in the 
medium, and a prolongation of incubation time up to 144h did not presents significant 
improvement in bioconversion performance. Also P. taetrolens DSM 21104 produced 
39.68±3.5 g/L of LBA (83±2% of conversion yield) after 144h of incubation in the same 
condition. pH, starting from 7 for both strains, achieved very low values after 144h of 
incubation: 3.55±0.02 and 3.59±0.12 for Pseudomonas taetrolens  LMG 2336 and 
Pseudomonas taetrolens DSM 21104 respectively (Fig. 4.12a and 4.12b). This low values of 
pH affected cell integrity and the bioconversion performance, so a constant value of pH may 
be improved LBA production, both as time and as yield.  
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a)   b)  
    Fig. 4.12. Specific growth rate (µ) [h
-1
], LOG CFU/mL, pH values, LBA product and  
    residual lactose [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) in  
    shake flasks with synthetic reach medium with concentrated lactose (50g/L of final 
    concentration), obtained after UF and NF processes on RCW, as substrate, inoculated with   
    5%vol/vol from bacterium medium preculture (condition C1). 
 
The possibility to use a cheaper medium (MSM) in comparison to synthetic reach medium for 
lactose oxidation was evaluated, as reported previously with chemically pure lactose from 
Sigma (paragraph 4.1.2). Despite the use of concentrated lactose, obtained from a natural 
matrix as RCW, presented positive effect on LBA production (6.15±1.36 and 4.1±1.28 g/L of 
LBA for Pseudomonas taetrolens  LMG 2336 and Pseudomonas taetrolens DSM 21104 
respectively after 144h of incubation at 30°C and 150 rpm) in comparison to the employed of 
Sigma lactose. But the low values of bioconversion yield (52±1.8 and 61±2,6 for 
Pseudomonas taetrolens  LMG 2336 and Pseudomonas taetrolens DSM 21104 respectively, 
after 144h of incubation) and maximum specific growth rate µmax (0.22±0.19 and 0.61±0.26 
h
-1 
for Pseudomonas taetrolens  LMG 2336 and Pseudomonas taetrolens DSM 21104 
respectively, after 3h of incubation), suggested how a reach medium was important for cells 
growth, which can produced in better condition and oxidized all the lactose initially present 
(50 g/L) (Fig. 4.12a and 4.12b). 
Peptone and yeast extract represent two important sources of nitrogenous substance for the 
growth medium (Alonso et al., 2011; 2013). If the cells need micronutrients and 
microelements, they use the lactose for LBA production as carbon source, encouraging the 
expression of enzymes used to the lactose molecule breakage into glucose and galactose.     
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a)   b)  
    Fig. 4.13. OD600, specific growth rate (µ) [h
-1
], LOG CFU/mL, pH values and LBA  
    product [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM 21104 (b) in shake  
    flasks with concentrated lactose (50g/L of final concentration), obtained after UF and NF  
    processes on RCW, as substrate, inoculated with 5%vol/vol from bacterium medium  
    preculture (condition C1). 
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4.2.4 Comparison between shake flasks experiments with chemically pure lactose from Sigma, 
RCW, permeate X, permeate 4 and synthetic reach medium supplemented with concentrated 
lactose, as substrates 
 
       
    Table. 4.1. Summary of maximum specific growth rate (µmax) [h
-1
], maximum LBA  
    product [g/L], pH and conversion yield values for P. taetrolens LMG 2336 and P.  
    taetrolens DSM 21104 in shake flasks experiments with chemically lactose from Sigma  
    and with natural lactose from RCW (RCW, permeate X, permeate 4 and concentrated 
    lactose after NF). 
 
In Alonso et al., 2011 high quantity of lactobionic acid production (35-40 g/L after 48 hours 
of incubation in shake flasks) by P.taetrolens LMG 2336 have been achieved employing a 
more nutrients rich raw material (cheese whey) and optimal conditions (inoculum size, 
nitrogen source supplementation and seed culture age).  
The importance of keep pH at constant values was also reported by Pedruzzi et al. 2007; 
indeed during the oxidation of lactose to LBA there is an intermediate structure, 
lactobionolactone molecule, which peak appears in HPLC chromatogram at low pH values. 
So a pH adjustment (alkaline hydrolysis) was necessary also for a high quality quantification 
analysis.   
As can be seen in Table 4.1 both tested P. taetrolens LMG 2336 and P. taetrolens DSM 
21104 in shake flasks experiments, show interesting bioconversion performance when 
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fermentative broth supplemented with concentrated lactose was employed as substrate. In an 
economic optimization noteworthy is the results with permeate 4, because it is obtained after 
separation of  bioactive proteins and peptides (through UF processes), but before NF process 
for obtaining concentrate lactose.    
Note how P.taetrolens LMG 2336 has two stages of growth 
  
4.3 SCALE UP IN PACKED-BED REACTORS (PBR) 
4.3.1 Preliminary tests for cells immobilization 
After different bioconversion experiments in shake flasks, with different kind of inoculum 
and substrates, were selected the best bacteria strains and culture conditions for performing 
reactors scale up. 
The importance of cells immobilization for improving growth and bioconversion 
performances, presented in a lot of papers, suggested the possibility to performed a Packed-
Bed Reactor (PBR) with the selected P. taetrolens strains (LMG 2336 and DSM 21104), but 
preliminary tested with different inorganic supports were needed previously. Three supports 
were investigated (Vukopor, Biopearl and SAGM500) for their material stability, that making 
them suitable for food applications, and, based on the observations reported in paragraph 
4.2.4, active cells in exponential phase growth in shake flasks RCW and inoculated from 
bacterium medium preculture (condition C1-paragraph 4.1.1) were used as inoculum for 
shake flasks with RCW and selected supports (Batch 1) and, after a long time of incubation 
(10 days) for promoting biofilm formation, supports with cells were used as inoculum in 
shake flasks with synthetic reach medium added with 50 g/L of concentrated lactose (UF+NF 
of RCW) (Batch 2).  
As reported in Fig. 4.15, in Batch 1 experiments were not detected significative difference in 
growth and pH values for both P. taetrolens strains between free cells colture (positive 
control) and the three supports coltures; maximun cell density of about 10
10
 CFU/mL starting 
from 10
7
 CFU/mL, was achieved after 48 h of incubation at 30°C and 80 rpm, lowest than 
150 rpm employed in previus screening experiments in order to encouraged cells attachment 
to the tested supports. Prolongation of incubation time and the starting of lactose oxidation to 
LBA, led to a decrease of pH values that, concurrently with substrate consuption, facilitated 
the creation of an adverse environment for growth, stimulating the cells to create a biofilm to 
guarantee their survival (Qureshi, 2005).  
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a)   b)  
    Fig. 4.14.  LOG CFU/mL and pH values for P. taetrolens LMG 2336 (a) and P.  
    taetrolens DSM 21104 (b) in shake flasks with RCW in 4 conditions (free cells, Vukopor  
    supports, Biopearl supports and SAGM500 supports), as substrate, inoculated with  
    10%vol/vol of cells growth in RCW shake flasks up to the exponential phase. 
 
No significant differences for LBA production, in comparison to free cells cultures, were also 
detected for the supports coltures in Batch 1 experiments, (Fig. 4.15a, 4.15b and 4.15d); and 
the conversion yield (Fig. 4.15d) confirmed the results obtained in bioconversion experiments 
for bacteria screening in shake flasks with RCW, as reported in Table 4.1: 0.88±0.03 and 
0.78±0.02 
 
for Pseudomonas taetrolens  LMG 2336 and Pseudomonas taetrolens DSM 21104 
respectively, after 72h of incubation at 30°C and 150 rpm.   
 
a)   b)  
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c)   d)  
    Fig. 4.15.  LBA product [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM  
    21104 (b), percentage variance in comparison to free cells cultures (c), and conversion 
    yield values (d)  in shake flasks with RCW with 3 selected supports (Vukopor, Biopearl 
    and SAGM500), as substrate, inoculated with 10%vol/vol of cells growth in RCW shake  
    flasks up to the exponential phase. 
 
After 10 days of incubations at 30°C and 80 rpm, the tested supports with cells biofilm were 
employed as inoculum in shake flasks with synthetic reach medium added with 50 g/L of 
concentrated lactose (UF+NF of RCW) (Batch 2) and incubated again in the same condition 
reported previously for Batch 1 (30°C and 80 rpm).  
Despite cell density (CFU/mL) and pH values were not presented differences between 
positive control (free cells shake flasks) and shake flasks with the free selected supports (Fig. 
4.16a and 4.16b), g/L of LBA product for both P. taetrolens strains were presented little 
changes for the three selected supports (Fig. 4.17). In particular P. taetrolens LMG 2336 was 
achieved 10.52±0.13 g/L of LBA, after 96 h of incubation, when Biopearl was employed as 
support, with 0.54±0.03 of conversion yield. Also P. taetrolens DSM 21104, with the same 
supports, was showed a little LBA production, even after 96 h of incubation: 3.67±0.14 g/L of 
LBA (0.25±0.02 of conversion yield).  
 
76 
 
a)   b)  
    Fig. 4.16.  LOG CFU/mL and pH values for P. taetrolens LMG 2336 (a) and P.  
    taetrolens DSM 21104 (b) in shake flasks with synthetic reach medium added with 50 g/L  
    of concentrated lactose (UF+NF of RCW) in 3 conditions (Vukopor supports, Biopearl 
    supports and SAGM500 supports), as substrate, inoculated with biofilm formed on supports  
    during Batch 1. 
 
a)   b)  
    Fig. 4.17.  LBA product [g/L] for P. taetrolens LMG 2336 (a) and P. taetrolens DSM  
    21104 (b) in shake flasks with synthetic reach medium added with 50 g/L  
    of concentrated lactose (UF+NF of RCW) in 3 conditions (Vukopor supports, Biopearl 
    supports and SAGM500 supports), as substrate, inoculated with biofilm formed on the  
    same supports during Batch 1. 
 
Despite only with Biopearl supports a little production of LBA was detected in batch 2, 
thanks to biofilm formation, also Vukopor supports were considerate for PBR setting up, for 
their particular structure with high specific surface that encouraged cells attachment. Indeed at 
the end of Batch 1 and Batch 2 both Vukopor and Biopearl supports were presented a visible 
biofilm on their surface, for the two tested P. taetrolens strains     
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4.3.2 Packed Bed Reactor (PBR) 
Preliminary experiments for biofilm formation on three selected supports (Vukopor, Biopearl 
and SAGM500), for P. taetrolens LMG 2336 and P. taetrolens DSM 21104 strains growth on 
RCW and synthetic reach medium added with 50 g/L of concentrated lactose (UF+NF of 
RCW), were led to the identification of the most promising supports and inoculum condition 
for PBR setting up. Two parallel reactors were performed with Vukopor and Biopearl (Fig. 
4.18) 
 
                      a)    b)  
       c)  
78 
 
    Fig. 4.18.  Packed-Bed Reactor with Vukopor supports (a), Biopearl supports (b) and  
    setting up of the two configurations (c), for P. taetrolens LMG 2336 and P. taetrolens  
    DSM 21104 with RCW and synthetic reach medium added with 50 g/L of concentrated  
    lactose (UF+NF of RCW).  
 
In a first batch fermentations (Batch 1) each tested P. taetrolens strains (LMG 2336 and DSM 
21104 ) was inoculated in two parallel PBRs setting up with Vukopor or Biopearl supports 
and autoclaved RCW as bioconversion medium, with cells in exponential phase growth in 
RCW shake flasks, as previously reported in paragraph 4.3.1, in order to encouraged biofilm 
formation.  
 
a)   b)  
    Fig. 4.19.  Cellular growth [LOG CFU/mL], pH and bioconversion values [g/L] of residual  
    lactose, LBA and lactic acid in PBR with Vukopor supports (a) and Biopearl supports (b) 
    for P. taetrolens LMG 2336 with RCW (Batch 1). 
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a)   b)  
    Fig. 4.20.  Cellular growth [LOG CFU/mL], pH and bioconversion values [g/L] of residual  
    lactose, LBA and lactic acid in PBR with Vukopor supports (a) and Biopearl supports (b) 
    for P. taetrolens DSM 21104 with RCW (Batch 1). 
 
a)  
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b)  
    Fig. 4.21.  Cellular growth [LOG CFU/mL], pH and bioconversion values [g/L] of residual  
    lactose, LBA and lactic acid in PBR with Biopearl supports for P. taetrolens LMG 2336  
   with synthetic reach medium added with 50 g/L of concentrated lactose (UF+NF of RCW)  
   (a) and RCW(b) (Batch 2). 
 
In batch 1 pH was not kept constant in order to stimulate the development of a challenging 
environment to incentivized the strains to adhere to media; in the batch 2 instead it was kept 
on values included between 5.5±0.55 E 6.5±0.65.  
In PBR experiments was important a preliminary phase of removal of deposits resulting from 
the precipitation of the proteins in an autoclave which can cause blockages in the reactor 
piping. 
 
4.4 SCALE UP IN STIRRED-TANK REACTORS (STR) 
The complications that were observed in PBR setting up, as reported previously, suggested 
the possibility to performed a different scale up in Stirred-Tank Reactors (STRs), in order to 
guarantee a constant pH value and an uniformly oxygen dissolved . 
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4.4.1 Batch fermentations in 3L-STR 
 
    a)    b)   
   Fig. 4.22.  3L-STR with autoclaved synthetic reach medium added with 50 g/L of   
   concentrated lactose (UF+NF of RCW) (a) and autoclaved RCW (b) as substrates,  
   inoculated with P.taetrolens LMG 2336 and P.taetrolens DSM 21104, in batch  
   configuration. 
 
The bioreactors were inoculated with 5% (v/v) of overnight precultures grown on nutrient 
broth medium, in order to minimized cellular stress during biomass recovery processes. When 
autoclaved RCW was employed as substrate, After 6-8 h of incubation, the cultures reached 
the maximum cell count (9.15x10
9
 CFU/ml) with a maximum specific growth rate of 0.25/h. 
The oxygen uptake shows the onset of growth phase (until 6-8 hours), with low values of 
pO2, and the start of stationary and LBA production phase.  After 48 hours of incubations P. 
taetrolens LMG 2336 produced 34,25±2,86 g/L of LBA (with 85±7% of conversion yield) 
(Fig. 4.23a). Interesting yields were also achieved with P. taetrolens DSM 21104 (Fig. 4.23b), 
producing 30,18±0,3 g/L LBA (with 84±7% of conversion yield) after 48 hours of batch 
fermentation. For both strains, prolongation of the incubation up to 80 h did not results in 
improving the productivities and a residual lactose concentration of about 4 g/l was observed 
starting from an initial concentration of 40 g/l. This could be due to the cell death as a result 
of increasing concentration of LBA and or the depletion of cofactors affecting the enzymatic 
activities. 
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The bioreactor results were comparable to those obtained in shake flasks experiments, but it 
could be noticed an important reduction of the time required for a total lactose consumption 
(from 120 to 48 hours), thanks to a constant parameters control. This aspects is very important 
for an improvement in bioconversion performance through fed-batch and continuous 
configurations.  
The yields obtained from RCW are slightly lower compared to those obtained by Alonso et al. 
(2011). In that study,  a concentration of 42.4 g/L of LBA and a bioconversion yield of 100% 
were obtained, after 32 hours, from sweet cheese whey using the strain P. taetrolens 
LMG2336 and an inoculum of 30% v/v. The higher LBA concentration and bioconversion 
yield observed could be due to the higher cell density used as inoculum and or to the higher 
protein content of the cheese whey compared to RCW (Alonso et al., 2011). The yields 
obtained here are lower compared to those obtained by Pedruzzi et al. (2011) where a LBA 
concentration of 125.4 g/L was achieved. However, in that study the process was based on the 
use of enzymes and pure lactose solution. Higher LBA titres were also achieved by Alonso et 
al. (2013) obtaining 164g/l of lactobionic acid. However, the experimental conditions were 
different from those applied here i.e. the process was a fed-batch and a co-feeding of 
concentrated lactose solution and highly concentration cheese whey solution supplemented 
with yeast extract and peptone was adopted.  
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a)   b)  
    Fig. 4.23.  Cellular growth [LOG CFU/mL], specific growth rate [h
-1
] and bioconversion 
    values [g/L] of residual lactose, LBA and lactic acid in 3L-STR with autoclaved RCW as  
    substrate for P.taetrolens LMG 2336 (a) and P.taetrolens DSM 21104 (b), in batch  
    configuration. 
 
       
a)   b)  
    Fig. 4.24.  Cellular growth [LOG CFU/mL], specific growth rate [h
-1
] and bioconversion 
    values [g/L] of residual lactose, LBA and lactic acid in 3L-STR with autoclaved synthetic  
    reach medium added with 50 g/L of concentrated lactose (UF+NF of RCW) as  
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    substrate for P.taetrolens LMG 2336 (a) and P.taetrolens DSM 21104 (b), in batch  
    configuration. 
 
When autoclaved synthetic reach medium added with 50 g/L of concentrated lactose (UF+NF 
of RCW) (Fig 4.24) and permeate 4 (30KDa-UF) (Fig. 4.25) as substrates for P.taetrolens 
LMG 2336 and P.taetrolens DSM 21104, in batch configuration, growth rate are better in 
comparison with RCW 3L-STR experiments, but the LBA titres were not presented 
significate improvement. 
 
         
    Fig. 4.25.  Cellular growth [LOG CFU/mL], specific growth rate [h
-1
] and bioconversion 
    values [g/L] of residual lactose, LBA and lactic acid in 3L-STR with autoclaved permeate 4  
    as substrate for P.taetrolens LMG 2336, in batch configuration. 
 
4.4.2 Fed-Batch fermentations in 3L-STR 
Fed batch fermentations, employed P.taetrolens LMG 2336 (Fig. 4.26) with RCW, 
supplemented after total lactose consumption (80h) with concentrated lactose led to achieved 
a 60 g/L of LBA, demonstrating how a continue supplemented of lactose can improve the 
performance of the process. 
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    Fig. 4.26.  Cellular growth [LOG CFU/mL], specific growth rate [h
-1
] and bioconversion 
    values [g/L] of residual lactose, LBA and lactic acid in 3L-STR with autoclaved permeate 4  
    as substrate for P.taetrolens LMG 2336, in fed-batch configuration with concentrated  
    lactose (UF+NF of RCW). 
 
4.4.3 Batch fermentations in 15L-STR 
 
      
    Fig. 4.27.  15L-STR with autoclaved RCW as substrate, inoculated with P.taetrolens LMG  
    2336, in batch configuration. 
 
STR cultivations were inoculated with 10% (v/v) from overnight precultures in order to avoid 
contaminations and cell stress. The oxygen uptake shows the onset of growth phase (until 6-8 
hours), with low values of pO2, and the start of stationary and production phase (from 12 to 
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48 hours), without oxygen consumption. Two different working volumes have been tested (5L 
and 7L) to evaluate the influence of headspace on fermentation yield (66.6% and 53% 
respectively).  
Pseudomonas taetrolens LMG (Fig.4.28) shows better performance with a lower headspace 
(53% corresponding to 7L of working volume), producing 46.69±3.63 g/L LBA (with 
0.89±0.05 of conversion yield) after 48 hours using all the initial lactose substrate. In the 
same conditions a 66.6% of headspace has been led to a reduction of 28.5% in the LBA 
production and of 18% in the conversion yield (33.37±0.65 g/L LBA with 0.73±0.02 of 
conversion yield).  
The LBA production is a non-growth related product and the starter of the stationary 
(coincides with the production phase) was indicated by the maximum specific oxygen 
consumption, as reported by Alonso et al. (2012). So a lower headspace, and a consequent 
lower oxygen presence in the reactor, during the fermentation phase has been a positive effect 
in cells oxidation performance. 
The influence of dissolved oxygen availability on cell growth and LBA production from 
cheese whey by Pseudomonas taetrolens LMG has been investigated by Alonso et al. (2012) 
and the results have been showed how  the use of high aeration rates neither stimulated cell 
growth nor lactobionic acid production due to a prolonged proliferation phase that delayed the 
onset of the production phase. 
 
 
    Fig. 4.28.  Production of LBA and residual lactose for P. taetrolens LMG in Stirred-Tank  
    Reactor-15L with autoclaved RCW (5L and 7L of working volume) 
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From the various screening in shake flasks is known as LMG 2336 is little influenced by the 
variability of the substrate, instead DSM 21104 has poor reproducibility in the growth and 
production values (as evidenced by the much higher standard deviations). 
 
4.5 DOWNSTREAM PROCESS FOR LBA RECOVERY  
4.5.1 High-Performance Tangential Flow Filtration 
 
 
Fig. 4.29.  Bench-scale cross flow unit (from PS Prozesstechnik GmbH) 
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The membrane employed has been characterized by a calibration line between flow (ml/sec) 
and pressure (bar) with demineralized water (Fig.4.29) 
  
 
Fig.4.30: Membrane calibration 
 
For each test has been performed a product calibration (Fig.4.31, Fig.4.32, Fig.4.33) 
  
 
Fig.4.31: Product calibration (test 1: pH3) 
 
 
Fig.4.32: Product calibration (test 2:pH9) 
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Fig.4.33: Product calibration (test 3: pH5.44) 
 
As can we see low pH values led to a high flow rate thanks to the minimized membrane pores 
fouling.  
For each test the filtration and diafiltration flow have been reported in the figures below 
(Fig.4.34, 4.35, 4.36, 4.37, 4.38, 4.39).  
 
 
Fig.4.34: Filtration Flow (test 1: pH 3) 
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Fig.4.35: Diafiltration Flow (test 1:pH3) 
 
 
Fig.4.36: Filtration Flow (test 2: pH 9) 
 
 
Fig.4.37: Diafiltration Flow (test 2: pH 9) 
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Fig.4.38: Filtration Flow (test 3: pH 5.44) 
 
   
Fig.4.39: Diafiltration Flow (test 3: pH 5.44) 
 
The evolution of flow with time (min) at 30°C and different pH values shows a diminution of 
filtration flow at extreme pH values (3 and 9) probably for pores fouling; but this effect was 
not relevant at pH 5.44, where the flow was smaller but constant with time. 
The quantification analyses of the samples, performed by HPLC system for LBA detection, 
have been reported in Table 4.2 and Table 4.3, for pH 3 and pH 9 respectively. 
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Table 4.2: Evolution of LBA amount during the diafiltration cycle at pH 3, 30˚C and 14-15 
bar (test 1: pH 3) 
 
 
Table 4.3: Evolution of LBA amount during the diafiltration cycle at pH 9, 30˚C and 14-15 
bar (test 2: pH 9) 
 
It is cleary how the pH value affects the LBA recovery; after 1 cylce of diafiltration process 
the LBA recovery was 32% at pH 9. No recovery was observed at pH 3. 
Finally a comparison with test 3 (pH 5,44 - intermediate between 3 and 9) has been presented 
in Table 4.4. 
 
 
Table 4.4: Comparison of test 1 (pH 3), test 2 (pH 9) and test 3 (pH 5,44) at 30˚C and 14-15 
bar (1KDa) 
 
Results confirm that pH 9 encourages LBA flow through the ceramic membrane (1KDa) and  
additional diafiltration cycles could lead to further increases in LBA recovery from 
fermentative broth.  
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Furthermore it can be seen how at low pH the material balance between initial and final LBA 
was not respected, probably due to a conformational change of the molecule, as reported 
previously by Pedruzzi et al. (2007). 
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5. CONCLUSION 
 
Disposal and treatment of dairy industry by-products (cheese whey and ricotta cheese whey) 
is a crucial challenge for dairy industry both as environmental and economicic point of view.  
Microbial production of LactoBionic Acid, a novel and interesting high-value added molecule 
for industry, may overcome the major drawbacks associated with chemical and enzymathic 
approaches (costs and harmful operative conditions) and a complete transition to industrial 
implemetation needs improvment three important aspects: high level cells density and 
stability (metabolic engineering strategies), efficient scale up configuration and optimization 
of downstream process with the aim of achieving an integrated continue biorefinery process 
for LBA bioproduction from inexpensive dairy industry feedstock. 
RicottaCheeseWhey, the byproduct of ricotta cheese manufacturing currently used mainly for 
feed preparation, and different permeates were used as a raw material for growth and LBA 
production by P. taetrolens strains. After shake flasks screening, in order to individuate the 
best condition of fermentation, in 3L-STR batch processes, fermentation and bioconversion 
yields of about 36g/L of LBA with 85% of conversion yield were achieved after 48 h. 
Furthermore fed-batch configuration and scale up in 15L-STR allowed to achieve better 
performance in term of  LBA production and time of reaction, respectively.  
To the best of our knowledge, this study shows for the first time that bovine RCW, a substrate 
completely different from cheese whey, can be used as substrate for the growth and 
production of lactobionic acid with results comparable to those obtained using cheese whey 
(Alonso et al., 2011). Moreover, it is worthy to stress that RCW is a dairy waste having high 
COD and BOD values and its disposal without treatment could create environmental 
problems. 
The use of lactose from a natural matrix from dairy industry waste, like RCW or permeates 
after filtration processes for recovering of bioactive proteins and peptides, improve 
bioconversion capacity of Pseudomonas taetrolens species for producing LBA via lactose 
oxidation reaction. Also interesting to note that despite the matrix is subject to fluctuations in 
the composition and properties arising from the initial raw material (milk and cheese-making 
processes), the strains of P. taetrolens are affected in a manner of little relevance. 
The proposed biotechnological process offers an interesting approach for the valorization of 
RCW into highly valuable fine chemical. A more detailed investigation on the effects of 
feeding strategy, inoculum size or the agitation on LBA productivity was beyond the 
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objective of the present preliminary screening.  Optimization of the bioconversion process 
through response surface methodology, a fed-batch process and the evaluation of the effect of 
cell immobilization on LBA yields is advisable. Moreover, set up of the downstream process 
for the recovery of LBA remains necessary for industrial exploitation/implementation of this 
biorefinery process.   
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